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Repeated exposure to chemical allergens increases the risk of becoming sensitized. Once an 
individual has become sensitized, any following exposure to the same chemical may result in 
allergic contact dermatitis (ACD). 
The risk to develop ACD is considered a serious health issue and the identification of potential 
sensitizing agents within consumer products is therefore crucial. With the enforcement of the 
7th Amendment to the EU Cosmetics Directive (76/768/EEC) in March 2013, currently known 
as the Cosmetics Regulation (EU 1223/2009), a ban on the use of animals was introduced for 
identifying repeated dose toxicity endpoints of chemicals used in cosmetic ingredients and 
products. This ban results in an urgent need for the development of suitable non-animal 
methods for safety testing. The development of animal alternatives has become even more 
urgent due to the Registration, Evaluation, Authorisation and Restriction of CHemicals 
(REACH) regulation, which may demand toxicity tests for chemicals produced in quantities of 
over 1 ton per year. Over the last years, many in vitro models have been proposed to identify 
the potential of chemicals to induce skin sensitization to meet current animal welfare, public 
opinions and legislation constrains. The development of in vitro, in chemico or in silico models 
for predicting the sensitizing potential of new chemicals is receiving widespread interest. 
Keratinocytes (KCs) play a key role in skin sensitization, as they provide the essential danger 
signals, they are involved in the protein haptenation process, and supply enzymes that are 
necessary for the metabolic activation of prohapten. 
Human KCs constitutively express several cytokines, including pro-interleukin (IL)-1, pro-IL-
1 and pro-IL-18. Evidences provided from our group has shown that IL-18 production in 
human KCs can be used as a sensitive method to identify contact allergens, discriminating 
them from respiratory allergens and irritants with a sensitivity of 87%, specificity of 95% and 
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an accuracy of 90%. IL-18 is synthesized as preform, which require proteolytic maturation by 
cysteine protease caspase-1, which must first be activated by the inflammasome.  
More recently, we demonstrated the possibility of combining the Reconstituted human 
Epidermis (RhE) potency assay with the assessment of IL-18 release to provide a single test 
for identification and classification of skin sensitizing chemicals, including chemicals of low 
water solubility or stability (Gibbs et al., 2013). In addition to being able to determine whether 
or not a chemical is a sensitizer (labelling) it is also equally important to determine the 
potency of a sensitizer (classification) in order to identify a maximum safe concentration for 
human exposure (risk assessment).  
 
The purpose of this thesis was to understand the role of several genes and proteins involved 
in contact allergen-induced NLRP3 inflammasome activation and IL-18 production, and their 
possible correlation with allergenic potency.  
Another objective of this thesis was to extend the list of chemicals tested in the RhE IL-18 
potency assay, and to provide a simple method for the in vitro estimation of the expected 
sensitization induction level.  
 
Results obtained during these three years of research activity have shown that several 
proteins involved in NLRP3 inflammasome activation/regulation were modulated by contact 
allergens. In particular I focused my attention on the role of NLRP12 and B lymphocyte 
induced maturation protein-1 (Blimp-1) in IL-18 production. The expression of NLRP3, ASC 
and caspase-1 activation were investigated by Western blot analysis and the NLRP12 
localization characterized by immunoprecipitation.  
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Regarding potency classification the results obtained using RhE IL-18 potency assay are very 
promising, and further compounds should be tested to better define the applicability and 
limitation of RhE IL-18 potency test. 
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                                                                                   CHAPTER ONE  
                                                                           INTRODUCTION  
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During the last few decades, the prevalence of allergic diseases has increased dramatically. 
The industrialized countries have faced a significant increase, although the rate of increase 
has recently slowed, of allergic diseases like atopic rhinitis, bronchial asthma, urticaria and 
allergic contact dermatitis. Within the North American and Western European populations, 
the prevalence of skin sensitization is approximately 20% (Peiser et al., 2012).  This increased 
prevalence has been attributed to complex interactions between environmental factors and 
genetic factors (Kim et al., 2014).  
Hypersensitivity reactions are often considered a major health problem in relation to 
environmental chemical exposure. Chemicals that are frequently reported to induce 
sensitization include products of plants and trees, such as abietic acid and balsam of Peru, 
metal ions, such as nickel, fragrances and cosmetic ingredients, such as cinammic aldehyde, 
geraniol, eugenol, p-phenylenediamine (PPD), etc.  
ACD is an inflammatory skin disease. Human skin is the largest organ of the body, making up 
16% of body weight, with several functions, the most important being to form a physical 
barrier to the environment, allowing and limiting the inward and outward passage of water, 
electrolytes and various substances while providing protection against microorganisms, 
ultraviolet radiation, toxic agents and mechanical insults. The regulation of skin defense 
mechanisms is crucial, as inappropriate or misdirected immune activities are implicated in the 
pathogenesis of a large variety of acquired inflammatory skin disorders, including psoriasis, 
atopic and allergic contact dermatitis, lichen planus, alopecia areata and vitiligo (Kadunce et 
al., 1995).  
 There are three structural layers in the skin: the epidermis, the dermis and the hypodermis 
(subcutis). Hair, nails, sebaceous, sweat and apocrine glands are regarded as derivatives of 
skin (Fig. 1). 
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Fig. 1 Cross-section of the skin [1] 
 
Skin is a dynamic organ in a constant state of change, as cells of the outer layers are 
continuously shed and replaced by inner cells moving up to the surface. Although structurally 
consistent throughout the body, skin varies in thickness according to anatomical site and age 
of the individual. The epidermis is the outer layer, serving as the physical and chemical barrier 
between the interior body and exterior environment; the dermis is the deeper layer providing 
the structural support of the skin, below which is a loose connective tissue layer, the subcutis 
or hypodermis which is an important depot of fat.  
The epidermis is a stratified squamous epithelium. The main cells of the epidermis are the 
KCs. Protein bridges called desmosomes connect the KCs, which are in a constant state of 
transition from the deeper layers to the superficial (Fig. 2). The four separate layers of the  
epidermis are formed by the differing stages of keratin maturation. The epidermis varies in 
thickness from 0.05 mm on the eyelids to 0.8 ± 1.5 mm on the soles of the feet and palms of 
the hand.  
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Fig. 2 Layers of the epidermis [2] 
Moving from the lower layers upwards to the surface, the four layers of the epidermis are:  
 Stratum basale (basal or germinativum cell layer); 
 Stratum spinosum (spinous or prickle cell layer); 
 Stratum granulosum (granular cell layer); 
 Stratum corneum (horny layer).  
In addition, the stratum lucidum is a thin layer of translucent cells seen in thick epidermis. It 
represents a transition from the stratum granulosum and stratum corneum and is not usually 
seen in thin epidermis. Together, the stratum spinosum and stratum granulosum are 
sometimes referred to as the Malphigian layer.  
Stratum basale. The innermost layer of the epidermis which lies adjacent to the dermis  
comprises mainly dividing and non-dividing KCs, which are attached to the basement 
membrane by hemidesmosomes. As KCs divide and differentiate, they move from this deeper 
layer to the surface. Making up a small proportion of the basal cell population is the pigment 
(melanin) producing melanocytes. These cells are characterized by dendritic processes, which 
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stretch between relatively large numbers of neighbouring KCs. Melanin accumulates in 
melanosomes that are transferred to the adjacent KCs where they remain as granules. 
Melanin pigment provides protection against ultraviolet (UV) radiation; chronic exposure to 
light increases the ratio of melanocytes to KCs, so more are found in facial skin compared to 
the lower back and a greater number on the outer arm compared to the inner arm. The 
number of melanocytes is the same in equivalent body sites in white and black skin but the 
distribution and rate of production of melanin is different. Intrinsic ageing diminishes the 
melanocyte population. Merkel cells are also found in the basal layer with large numbers in 
touch-sensitive sites such as the fingertips and lips. They are closely associated with 
cutaneous nerves and seem to be involved in light touch sensation.  
Stratum spinosum. As basal cells reproduce and mature, they move towards the outer layer 
of skin, initially forming the stratum spinosum. Intercellular bridges, the desmosomes, which 
appear as ‘prickles’ at a microscopic level, connect the cells. Langerhans cells (LC) are 
dendritic, immunologically active cells derived from the bone marrow, and are found on all 
epidermal surfaces but are mainly located in the middle of this layer. They play a significant 
role in immune reactions of the skin, acting as antigen-presenting cells (APC).  
 In addition, T cells, mainly CD8+ T cells, can be found in the stratum basale and stratum 
spinosum (Krueger et la., 1989). 
Stratum granulosum. Continuing their transition to the surface the cells continue to flatten, 
lose their nuclei and their cytoplasm appears granular at this level.  
Stratum corneum. The final outcome of keratinocyte maturation is found in the stratum 
corneum, which is made up of layers of hexagonal-shaped, non-viable cornified cells known 
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as corneocytes. In most areas of the skin, there are 10 ± 30 layers of stacked corneocytes with 
the palms and soles having the most. Each corneocyte is surrounded by a protein envelope 
and is filled with water-retaining keratin proteins. The cellular shape and orientation of the 
keratin proteins add strength to the stratum corneum. Surrounding the cells in the 
extracellular space are stacked layers of lipid bilayers. The resulting structure provides the 
natural physical and water-retaining barrier of the skin. The corneocyte layer can absorb three 
times its weight in water but if its water content drops below 10% it no longer remains pliable 
and cracks. The movement of epidermal cells to this layer usually takes about 28 days and is 
known as the epidermal transit time.  
Dermoepidermal junction/basement membrane is a complex structure composed of two 
layers. The structure is highly irregular, with dermal papillae from the papillary dermis 
projecting perpendicular to the skin surface. It is via diffusion at this junction that the 
epidermis obtains nutrients and disposes of waste. The dermoepidermal junction flattens 
during ageing which accounts in part for same of the visual signs of ageing.  
The dermis varies in thickness, ranging from 0.6 mm on the eyelids to 3 mm on the back, 
palms and soles. It is found below the epidermis and is composed of a tough, supportive cell 
matrix. Two layers comprise the dermis: 
 a thin papillary layer; 
 a thicker reticular layer.  
The papillary dermis lies below and connects with the epidermis. It contains thin loosely 
arranged collagen fibres. Thicker bundles of collagen run parallel to the skin surface in the 
deeper reticular layer, which extends from the base of the papillary layer to the subcutis 
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tissue. The dermis is made up of fibroblasts, which produce collagen, elastin and structural 
proteoglycans, together with immunocompetent mast cells and macrophages. Collagen fibres 
make up 70% of the dermis, giving it strength and toughness. Elastin maintains normal 
elasticity and ̄exibility while proteoglycans provide viscosity and hydration. Embedded within 
the fibrous tissue of the dermis are the dermal vasculature, lymphatics, nervous cells and 
fibres, sweat glands, hair roots and small quantities of striated muscle.  
Subcutis is made up of loose connective tissue and fat, which can be up to 3 cm thick on the 
abdomen.  
Blood and lymphatic vessels. The dermis receives a rich blood supply. A superficial artery 
plexus is formed at the papillary and reticular dermal boundary by branches of the subcutis 
artery. Branches from this plexus form capillary loops in the papillae of the dermis, each with 
a single loop of capillary vessels, one arterial and one venous. The veins drain into mid-dermal 
and subcutaneous venous networks. Dilatation or constriction of these capillary loops plays a 
direct role in thermoregulation of the skin. Lymphatic drainage of the skin occurs through 
abundant lymphatic meshes that originate in the papillae and feed into larger lymphatic 
vessels that drain into regional lymph nodes.  
Nerve supply. The skin has a rich innervation with the hands, face and genitalia having the 
highest density of nerves. All cutaneous nerves have their cell bodies in the dorsal root ganglia 
and both myelinated and non-myelinated fibres are found. Free sensory nerve endings lie in 
the dermis where they detect pain, itch and temperature. Specialized corpuscular receptors 
also lie in the dermis allowing sensations of touch to be received by Meissner's corpuscles 
and pressure and vibration by Pacinian corpuscles. The autonomic nervous system supplies 
the motor innervation of the skin: adrenergic fibres innervate blood vessels, hair erector 
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muscles and apocrine glands while cholinergic fibres innervate eccrine sweat glands. The 
endocrine system regulates the sebaceous glands, which are not innervated by autonomic 
fibres.   
As well acting as a physical barrier, skin also plays an important immunological role (Kupper 
et al., 2004). It is possible to explain it when the skin is stressed by several stimuli.  
Allergic contact dermatitis (ACD) is a type of inflammation of the skin and it is the most 
prevalent form of immunotoxicity in humans in industrialized countries. It can be induced 
after skin contact with chemical haptens, and develops through a series of immunological 
events caused by repeated contact with compounds that have skin sensitizing potential 
(Kimber et al., 2002).  It is characterized by clinical manifestations such as red rashes, itchy 
and blisters. Haptens have two important characteristics: proinflammatory properties and 
immunogenicity (Vocanson et al., 2009). Their proinflammatory properties provide the first 
signal that is necessary for innate immunity activation resulting in Dendritic Cells (DCs) 
activation, migration and maturation. Their immunogenicity depends on hapten-protein 
complex presentation in the groove of the Major Histocompatibility Complex (MHC) class I/II 
molecules on DC. 
All contact allergens share some common features: they have low molecular weight (<1000  
Da), they need to bind to epidermal proteins to form hapten-protein complex, which is 
actually immunogenic (Krasteva et al., 1999). These small molecules establish stable covalent 
links with endogenous proteins (Divkovic et al., 2005). Prehaptens to prohaptens 
transformation occurs upon chemical reactions (oxidation) or due to enzyme activity. Some 
prehaptens are transformed by UV radiation (Basketter et al., 1995).  
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ACD is a typical type IV (delayed-type) hypersensitivity response that develops in two phases, 
the initiation phase in which the immune system is sensitized and the elicitation phase in 
which the clinical symptoms develop. The third phase, resolution phase, during which the 
recostitution of skin occurs. The sensitization phase (also referred to as afferent phase) of 
ACD occurs after the contact between haptens and skin, and lasts for 8-15 days in humans 
(Smith Pease et al., 2003). The first phase of ACD usually has no clinical consequences, but in 
some cases may present as primary acute ACD.  In Fig. 3 the pathogenesis of ACD is shown. 
     
Fig. 3 Pathogenesis of ACD [3] 
Following absorption through the stratum corneum haptens reach the viable part of the  
epidermis. KCs are key players in sensitization phase, as they contain enzymes that are 
required for the conversion of prohaptens into biologically active haptens (Naisbitt et al., 
2004). KCs also provide sets of alarmins and cytokines that generate a proinflammatory 
microenvironment, which is necessary for innate immune system activation.  
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Among alarmins, the Damage-Associated Molecular Patterns (DAMPs) are sensed by so-called 
Pattern Recognition Receptors (PRRs) such as the Toll-Like Receptors (TLRs) (Faulkner L. et 
al., 2014).  These receptors are involved in the first line of defense against pathogens. To date, 
ten different TLRs have been identified in humans (Boehme et al., 2004). The primary function 
of TLRs is the initial recognition of pathogenic microorganisms and subsequent activation of 
the innate immune response. Activated TLRs promote the phagocytosis of pathogens in 
innate immune cells such as macrophages and induce the production of reactive oxygen 
species (ROS), to neutralize pathogens. 
TLR2 and TLR4 play an important role in mounting a full immune response to skin sensitizers. 
Evidence for an involvement of the signaling pathway p38 Mitogen Activated Protein Kinase 
(p38 MAPK) in skin sensitization further underpin the relevance for TLR. P38 MAPK are 
enzymes that play an important role in the signal transduction of TLR (Mehrotra et al., 2007). 
In the keratinocyte cell line NCTC2544 IL-18 production induced by skin sensitizers was greatly 
decreased after addition of the specific p38 MAPK inhibitor, SB203580 (Galbiati et al., 2011). 
Similar results were obtained in an experiment using the monocytes THP-1 cell line (Mitjans 
et al., 2010), indicating that sensitizers activated p38 MAPK in both KCs and DCs. 
There is evidence that TLR4 has a role in the induction of ACD, which occurs in IL-12-
independent pathway (Martin et al., 2008). The exact role of TRL4 is not fully understood, but 
it seems that TLR4 may be required for the induction of cytokines in DC with impaired IL-12 
function.  A possible candidate cytokine induced by TLR4 activation is IL-23 (a member of IL-
12 family). IL-23 (like IL-12) participates in DCs activation and enhances hypersensitivity 
reaction (Martin et al., 2008). IL-23 stimulates (while IL-12 inhibits) IL-17-producing CD8+ 
cells. TLR2 is important for T-helper 1 response to cutaneous antigens. Skin is colonized with 
bacteria, which can be the source of TLR2 ligands. TLR2 promotes the Interferon (IFN)-γ 
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response to cutaneously introduced antigens (He et al., 2006). There are evidences that heat 
shock proteins (HSP27 and HSP70) form a link between adaptive and innate immunity during 
early stages of contact sensitivity. Their interaction with TLR4 increases the production of 
cytokines known to enhance antigen (Ag) presentation by T cells (Yusuf et al., 2009). TLR2 and 
TLR4 activation induces the production of Nuclear Factor-B-dependent (NFB) pro-
inflammatory cytokines and chemokines such as IL-6, IL-12, and tumor necrosis factor (TNF)-
𝛼, and of pro-IL-1𝛽 and pro-IL-18. The inflammasomes are required to activate and secrete 
several cytokines that are expressed as nonfunctional proteins after NFB activation (Nestle 
et al., 2009). 
Another important family of PRRs are the Nucleotide-binding Oligomerization Domain 
(NOD)-Like Receptors (NLRs). These intracellular receptors recognize pathogens-Associated 
Molecular Patterns (PAMPs) with the same leucine-rich repeat domains that can be found in 
TLRs. NLRs are activated by PAMPs such as bacterial RNA, flagellin and breakdown products 
of peptidoglycan (Feldmeyer et al., 2010). In addition, the NLRs are able to recognize DAMPs 
such as ATP and uric acid (Kawai & Akira, 2009). Upon activation, NOD receptors can activate 
NFB and the inflammasomes (Stutz et al., 2009; Feldmeyer et al., 2010; Latz, 2010).  
 
In skin, haptens are detected by KCs that react by the NLRP3 inflammasome activation. 
Secreted IL-1β and IL-18 induce KCs to release IL-1α, TNF-α and Granulocyte-Macrophage 
Colony-Stimulating Factor (GM-CSF), promoting the activation of DC, including epidermal LCs 
(Wang, 2002). As APC, LCs migrate towards lymph nodes from the dermis and activate a 
specific immune response (Fig. 3). Primary function of APC is to capture, process and present 
Ags to unprimed T cells (Zaba et al., 2009). DC has monocyte origin. Immature DCs reside in 
non-lymphoid tissues. They form a dense network in the skin and capture haptens 
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penetrating skin barrier. There are three kinds of DC populations in non-inflamed skin: 
epidermal LCs, dermal myeloid DCs (dDCs) and dermal plasmacytoid DCs (pDCs). During 
inflammation, another population of dermal DC occurs, “inflammatory” DCs (Zaba et al., 
2009). LCs are epidermal MHC class II DCs specialized in Ag presentation and reside in the 
suprabasal layers of the epidermis, close to KCs (Ryan et al., 2005). Zaba et al., 2009 have 
assumed that LCs processed antigens locally and migrated to lymph node for Ag presentation, 
and they believed that LCs have the role in inducing and maintaining tolerance to cutaneous 
antigens. It has also been shown that ACD response was not completely abrogated despite 
full abrogation of LCs, indicating that several types of DCs are involved in T-cell priming 
(Grabbe et al., 1995). Dermal myeloid DCs are a population of DCs residing in the dermis; they 
are able to take up Ags, mature and migrate to draining local lymph nodes and present them 
to B and T cells (Zaba et al., 2009). pDCs are a unique group of resident cutaneous DCs. While 
both mDCs and pDCs express high levels of HLA-DR and have Ag-presenting capacity, pDCs 
are characterized by their ability to produce large amounts of IFN-1 (Zaba et al., 2009). DCs 
respond differently to haptens and irritants with their production of cytokines and expression 
of co-stimulatory molecules (Aiba et al., 1997). Fully mature DC shows high expression of MHC 
class II and co-stimulatory molecules (Cluster of Differentiation (CD) 40, CD80, CD86) and also 
a decreased capacity to internalize antigens (Aiba et al., 1997). MHC II is constitutively 
expressed on LC, and expression of these molecules is strongly up-regulated by haptens and 
not irritants (Aiba et al., 1997). DC maturation can be induced by cytokines such as IL-1β, TNF-
α, CD40 ligation, expression of IL-12, viral RNA, lipopolysaccharides and contact sensitizers 
(Arrighi et al., 2001). Protein haptenization triggers maturation of DC, probably due to 
reactive cysteine residues and p38 activation. This process is primarily mediated by the 
activation of p38 MAPK and is caused by intracellular redox imbalance induced by contact 
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allergens (Megherbi et al., 2009). Although MAPK may play a crucial role in the activation of 
DCs, the upstream signals of p38 MAPK remain undetermined (Mizuashi 2005). IL-1β and TNF-
α both have a role in LC migration to lymph nodes (Nakae et al., 2001). IL-1α, IL-1β and TNF-
α levels are increased in contact-allergen sensitized skin. IL-1α is mainly produced by KCs, 
whereas IL-1β is mainly produced by LC, and both IL-1α and IL-1β can promote LC migration 
(Nakae et al., 2001). IL-1α is mainly involved in contact allergen-specific-priming, while IL-1β 
is involved in contact allergen-specific antibody production (Nakae et al., 2001). 
IL-12 is considered to be important in the generation of allergen-specific T cell response. 
Other surface molecules that are also expressed after the haptens intake are ICAM-1 (CD54) 
and B7-2 (CD86) (Aiba et al., 1997). 
Generated short-lived effector T cells and long-lived memory T cells migrate to peripheral 
tissue in order to participate in immune responses and immune surveillance. Relocation of 
effector and memory T cells is non-random, the process involves adhesion molecules, 
including selectins, integrins, and corresponding vascular ligands as well as the large family of 
chemokines and their receptors (Ebert et al., 2005). A fraction of primed T lymphocytes 
persists as circulating memory cells and can confer protection and give, upon secondary 
challenge, a qualitatively different and quantitatively enhanced response (Sallusto et al., 
1999). 
In the dermis, endothelial and lymphatic cells produce Chemochine ligand 19 (CCL19) and 
CCL21. These chemokines are recognized by the up-regulated CCR7 chemokine receptor of 
sensitizer-activated DCs, which migrate to afferent lymphatic vessels (Kaplan et al., 2012; 
Rustenmayer et al., 2011). The activation of sensitizer-specific naive T cells by activated DCs 
in the skin-draining lymph nodes is the crucial step and concludes the sensitization phase 
(Kaplan et al., 2012; Rustenmayer et al., 2011). Upon activation, T cells produce IL-2, which is 
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a T cell growth factor, resulting in abundant T cell expansion (Rustenmayer et al., 2011). 
Moreover, they receive instructive signals from the skin DCs, resulting in the expression of a 
combination of homing receptors, that is, chemokine receptors and adhesion molecules, that 
directs them to the skin. The immunological microenvironment (comprising the amount of 
sensitizer, danger signals, and other soluble mediators) determines the final phenotype of 
effector T cells. In the skin-draining lymph nodes, sensitizer-activated DCs produce IL-12 and 
IFN-γ, promoting the differentiation of Th1 cells, which release IFN-γ and TNF-α (Peiser et al., 
2012). The microenvironment containing IL-6, transforming growth factor (TGF)-β, IL-21, IL-
23 and IL-1β leads to Th17/22 polarization and the production of IL-17 and IL-22. The presence 
of IL-4 leads to Th2 polarization and subsequent IL-4, IL-5 and IL-13 production. IL-2 and TGF-
β in the microenvironment promote the differentiation of regulatory T cells (Tregs), which 
secrete immunosuppressive IL-10, an important cytokine that limits the extent and duration 
of ACD and promotes tolerance (Berg et al., 1995).  
It has been speculated that the strength of the innate inflammation caused by the contact 
sensitizer is responsible for the immunogenic or tolerogenic state of DCs and the subsequent 
effector/memory T cell/Treg ratio (Martin, 2012). Both sensitizing and tolerizing pathways are 
induced during sensitization, and the balance of these pathways determines the final 
outcome (Vocanson et al., 2010). 
Elicitation phase is also known as efferent or challenge phase (Fig. 3). A subsequent exposure 
to the haptens leads to a rapid activation of the specific lymphocyte(s) clone(s) and to activate 
and trigger inflammatory process responsible for cutaneous lesions (Rustemeyer et al., 2006).  
One of the important characteristics of memory CD8+ cell is their capacity to display 
immediate effector functions following Ag re-exposure (Walzer et al., 2003). This process lasts 
for several days and progressively decreases upon physiological down-regulating mechanisms 
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(Krasteva et al., 1999). A memory response to Ag is much faster than the primary response 
(Vocanson et al., 2009). Infiltration of hapten-specific effector and memory T cells causes local 
inflammatory response 24-72 h later (Krasteva et al., 1999; Martin et al., 2008). Recruitment 
of lymphocytes into inflamed skin is a multistep process and involves recognition of vascular 
endothelial cells and extravasations; there is a sequentional infiltration of the skin, CD8+ cells 
enter first, and then CD4+ cells due to differential expression of homing-receptors and 
sequentional expression of chemokines (Cavani et al., 2000). CD8+ cells infiltrate skin 9 h after 
hapten re-exposure, whereas CD4+ cells are recruited after 24 h and this fact is associated 
with diminishing the reaction severity (Akiba et al., 2002). IFN-γ is a key cytokine in local 
expression of inflammation during the first 24 h, and this inflammation is mediated by the 
production of KC-derived chemokines (such as IP-10, MIG, I-Tac acting on CXCR3 leukocyte 
chemokine receptors). MCP-1 and RANTES are the dominant monocyte/macrophage chemo-
attractants expressed during the elicitation phase (Goeberel et al., 2001). Both subsets of T 
cells, CD4+ and CD8+, mediate skin inflammatory reaction, however, more studies have 
shown that hapten-specific CD8+ cells can mediate reaction without CD4+ cells (Krasteva et 
al., 1999). CD8+ cells have the main effector role during elicitation phase, whereas CD4+ can 
have pathogenic and regulatory role. There are three steps in the development of elicitation 
phase of ACD: first step includes early recruitment of CD8+ cells and this is initiated 
via endothelial activation due to hapten-induced skin inflammation (Vocanson et al., 2009). 
Second step is activation of hapten-specific cells, and activation of skin-resident cells and 
cytokine and chemokine production. Third step is arrival of leukocytes to the skin, especially 
macrophages and neutrophils, and development of clinically observed reaction (Vocanson et 
al., 2009). 
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KCs are also important in the elicitation phase of ACD, because, upon re-exposure, they up-
regulate co-stimulatory molecules such as CD80, and are able to function as antigen-
presenting cells, facilitating activation of hapten-specific effector T cells (Ouwehand et al., 
2010). The identification of specific combinations of cytokines and chemokines as biomarkers 
that are unique to ACD is challenging. These mediators are commonly also found in other 
inflammatory conditions. However, it is tempting to hypothesize that the distinction between 
irritant contact dermatitis (ICD) and ACD could be made on the basis of T cell-related factors, 
as ICD does not involve antigen-specific T cells (Meller et al., 2007). Interestingly, CXCL9, 
CXCL10 and CXCL11 were recently found to be selectively up-regulated in human skin in 
nickel-induced ACD as compared with atopic dermatitis (AD) (Quaranta et al., 2014).  
 
To facilitate the use of in vitro methods an adverse outcome pathway (AOP) for skin 
sensitization was established (OECD, 2012). AOP is the sequence of events from the molecular 
initiating event to an in vivo outcome of interest. Each AOP represents the existing knowledge 
concerning the linkage between a molecular initiating event, intermediate events and an 
adverse outcome at the individual or population level. 
Knowledge of the AOP for skin sensitization has evolved rapidly over the past decade and four 
events that are recognized as key ones, have been identified (Fig. 4): 
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Fig. 4 Flow diagram of the pathways associated with skin sensitization [4] 
Following a brief description of each key events (KEs) is reported: 
1. The first key event is the interaction of the chemical with skin protein. Specifically, the 
target chemical or its metabolite or abiotic transformation product of the target 
chemical covalently binds to cysteine and/or lysine residues of skin proteins; 
2. The second key event takes place in the keratinocytes. It includes inflammatory 
responses as well as gene expression associated with specific cell signaling pathways; 
3. The third key event is the activation of dendritic cells, which is typically assessed by 
expression of specific cell surface markers and release of chemokines and cytokines. 
4. The final key event is the specific T cell clonal expansion, which is measured in the 
murine LLNA. 
 
In the last ten years the laboratory of toxicology has been interested in the development of 
alternative methods to identify contact allergens. In particular, attention focused on KEs 2 
and 3. Regarding KE 2, to investigate the role of KCs in allergic contact dermatitis, my 
experiments were conducted using human KCs cell line, NCTC 2544. NCTC 2544 is a 
commercially available skin epithelial-like cell line originating from normal human skin, which 
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posses a good expression of cytochrome P450-dependent enzymatic activities. NCTC 2544 is 
an immortalized, non-tumorigenic cell line, which grows in a monolayer.  
In previous studies, we showed that exposure to contact allergens, but not to respiratory 
allergens or irritants, resulted in a dose-related induction of intracellular IL-18. The assay 
proved to be useful in the identification and discrimination of contact allergens from 
respiratory sensitizers and irritants (Corsini et al., 2009, 2013; Galbiati et al., 2011). In the 
context of the sensitization process, the NCTC 2544 assay was designed to cover the initial 
phase ‘local trauma-proinflammatory cytokine production (danger signals)’, necessary for 
maturation and migration of dendritic cells, and T cells activation.  
IL-18, formerly known as IFN--inducing factor (IGIF), which belongs to the IL-1 cytokine 
family, has been shown to play a key proximal role in the induction of allergic contact 
sensitization and to favor Th-1 type immune responses by enhancing the secretion of 
proinflammatory mediators such as TNF-, IL-8 and IFN- (Okamura et al., 1995; 
Cumberbatch et al., 2001; Antonopoulos et al., 2008). IL-18 does not stimulate Th-2 cells 
(Robinson et al., 1997 and Kohno et al., 1997). This was shown using an assay in which IL-18 
induced translocation of NFB in Th-1 clones but not Th-2 cells. In these Th-2 clones, nuclear 
translocation of NFB was not observed following incubation with IL-18, whereas in the same 
cells IL-1 induced NFB activation and cellular proliferation (Robinson et al., 1997). In 
another study, Th-2 clones did not express mRNA for IL-18 Receptor  (IL-18Rα) (Xu et al., 
1998 and Yoshimoto at al., 1998), which may be the best explanation for the lack of 
IFN production by Th-2 cytokines. 
 IL-18 has no apparent role in ICD (Antonopoulos et al., 2008), indicating that the role of IL-18 
in contact hypersensitivity is not simply part of a general requirement for IL-18 in skin 
inflammation. Furthermore, Hartwig et al., 2008 demonstrated using IL-18-deficient mice that 
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the absence of IL-18 does not affect any of the asthma-specific parameters, including 
allergen-specific immunoglobulin E (IgE), histological changes of the lungs, infiltrating 
leukocytes, serum cytokine levels and airway hyperresponsiveness. Human keratinocytes 
constitutively express IL-18 mRNA and protein (Naik et al., 1999), and works published by Naik 
et al., 1999 and Van Och et al., 2005 showed the induction of IL- 18 following exposure to 
contact sensitizers. IL-18 and IL-1 have some common features: in terms of structure, IL-18 
and IL-1 share primary amino acid sequences of the so-called “signature sequence” motif 
and are similarly folded as all- pleated sheet molecules. IL-1, IL-18 are synthesized as a 
biologically inactive precursor molecule lacking a signal peptide which requires cleavage into 
an active, mature molecule by the intracellular cysteine protease called IL-1 converting 
enzyme (ICE) or caspase-1. The activity of mature IL-18 is closely related to that of IL-1. IL-18 
induces gene expression and synthesis of TNF, IL-1, Fas ligand, and several chemokines. The 
activity of IL-18 is via the IL-18R complex. The Fig. 5 is a working model of the proposed IL-18 
signaling resulting in translocation of NFB to the nucleus. IL-18R complex is made up of a 
binding chain termed IL-18R, a member of the IL-1 receptor family previously identified as 
the IL-1 receptor related protein (IL-1Rrp), and a signaling chain, also a member of the IL-1R 
family. IL-18 binds to the IL-18Rα chain (Torigoe et al., 1997) (also known as IL-1Rrp) and 
recruits the IL-18R chain. This heterodimeric complex recruits MyD88 and IL-1R Activating 
Kinase (IRAK). Phosphorylated IRAK activates TNFR-associated factor-6 (TRAF-6), and in turn, 
NFB-Inducing Kinase (NIK) is phosphorylated. This results in activation of IKK and then 
phophorylation of IB. Phosphorylated IB degrades and releases the p50 and p65 
components of NFB. Free NFB migrates through nuclear pores and translocate to nuclear 
DNA for gene transcription.  
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Fig. 5 Model for IL-18 signal transduction [5] 
 
Thus on the basis of primary structure, three-dimensional structure, receptor family, signal 
transduction pathways and biological effects, IL-18 is classified as a member of the IL-1 family. 
Similar to IL-1, IL-18 participates in both innate and acquired immunity. 
 
 
Signal transduction pathways involved in inflammasome activation. 
 
On the known basis of ACD mechanistic understanding, the relationship between reactivity 
of molecules toward proteins and their sensitization potential has increased interest and was 
used to develop experimental assay to predict the skin sensitization potential of chemicals to 
replace in vivo animal tests (Gerberick et al., 2008). 
As described, the innate immune system is composed of receptors that collectively serve as 
a sensor for monitoring the extracellular and intracellular compartments for sings of infection 
or tissue damage. A key component of cytosolic surveillance is the inflammasome, a large 
multimolecular complex that controls activation of the proteolytic enzyme caspase-1 
(Martinon et al., 2002). Caspase-1 in turn regulates maturation of the proinflammatory 
cytokines IL-1 and IL-18 or the rapid inflammatory form of cell death called “pyroptosis” 
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(Rathinam et al., 2012). The inflammasome was described a decade ago and contains a 
cytosolic PRR, typically a NLR or a non-NLR AIM2 [absent in melanoma 2 (AIM2)], the 
apoptosis-associated speck-like protein containing a CARD (ASC, also known as PYCARD) 
which harbours an N-terminal pyrin (PYD) domain and a CARD at C-terminus (Srinivasula et 
al., 2002) and the pro-caspase-1. The ASC configuration facilitates homotypic associations 
with other PYR and CARD containing proteins required for inflammasome assembly by linking 
the NLR with pro-caspase-1. The stimuli, the supposed mechanisms, the structure of the 
known inflammasomes and the key proteins are illustrated in Fig. 6: 
 
 
Fig. 6 Inflammasome subtypes and organization [6] 
 
The NLRP3 (CIAS, NALP3, cryopyrin) inflammasome is unique amongst inflammasomes in 
being responsive not only to microbial cues but also a plethora of chemically diverse non-
microbial signals arising from, for example, monosodium urate (Martinon et al., 2006), 
glucose (Zhou et al., 2010) extracellular ATP (Mariathasan et al., 2006) as well as PAMPs 
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(Mariathasan et al., 2006; Craven et al., 2009). The NLRP3 couples directly to the PYD of ASC 
via its PYD domain to execute function. 
Among the NLRs, NLRP1 (NALP1) inflammasome is the original oligomeric complex discovered 
consisting of caspase-1, caspase-5, NLRP1 and ASC (Martinon et al., 2002). It is presently the 
only known inflammasome containing a FIIND (function to find) domain, which undergoes 
autocleavage to confer functionality (Finger et al., 2012). Both anthrax lethal factor from 
Bacillus anthracis (Boyden and Dietrich, 2006) and muramyl dipeptide (Faustin et al., 2007) 
initiate its activation. 
The NLRC4 (IPAF) inflammasome is characterized by the presence of an intrinsic CARD domain 
that interacts directly with procaspase-1 (Mariathasan et al., 2004). The main triggers for this 
inflammasome are bacterial flagellins of gram-negative bacteria with type III or IV secretion 
systems exemplified by Salmonella typhimurium and Shigella flexneri (Mariathasan et al., 
2004; Amer et al., 2006; Miao et al., 2006; Franchi et al., 2006). Activation has also been 
shown to be flagellin-independent (Suzuki et al., 2007) indicating that other, as yet unknown, 
bacterial ligands are also sensed by NLRC4. 
The non-NLR AIM2 inflammasome belongs to the haematopoetic expression, IFN-inducible, 
nuclear localization and length of 200 aminoacid domain (HIN200) family (Burckstummer et 
al., 2009; Fernandes-Alnemri et al., 2009). It is distinct from the NLR inflammasomes in having 
a HIN group containing a PYD domain that associates with the PYD of ASC to effect function. 
AIM2 detects double-stranded DNA within the cytosol (Fernandes-Alnemri et al., 2009; 
Rathinam et al., 2010) for which direct binding has been demonstrated (Hornung et al., 2009). 
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Among NLR inflammasome complexes, the NLRP3 inflammasome has been the most widely 
characterized and is a crucial signaling node that controls the maturation of IL-1 and IL-18 
(De Nardo et al., 2011). 
Activation of the NLRP3 inflammasome is thought be regulated at both the transcriptional 
and post-translational levels (Vanaja et al., 2015). The general mechanisms by which NLRP3 
inflammasome is activated are summarized in Fig. 7.  
 
 
Fig. 7 NLRP3 activation [7]  
 
The first signal in inflammasome activation involves the priming signal, mediated by microbial 
ligands recognized by TLRs or cytokines such as TNF-α. Signal 1 activates the NFB pathway, 
leading to up-regulation of pro-IL-1/pro-IL-18 and NLRP3 protein levels. The signal 2 is 
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mediated by numerous PAMP or DAMP stimulation, and promotes the assembly of ASC and 
pro-caspase-1, leading to activation of the NLRP3 inflammasome complex (Franchi et al., 
2010).  
Briefly, molecular mechanisms suggested for NLRP3 activation to induce caspase-1 activation 
and IL-1/IL-18 maturation are: pore formation and potassium (K+) efflux, mitochondrial ROS 
generation and lysosomal destabilization and rupture. Evidence supports that the aberrant 
activation of the NLRP3 inflammasome is associated with the pathogenesis of various 
autoinflammatory, autoimmune, and chronic inflammatory and metabolic diseases. Thus, 
activation of the NLRP3 inflammasome should be tightly regulated to prevent unwanted host 
damage and excessive inflammation.  
The three molecular mechanisms suggested are following described: physiologically, cytosolic 
K+ levels in all cells at rest are high with a substantial exit of intracellular K+ ions warning the 
cell of danger. A change in K+ ion concentration induces cleavage of immature IL-1 and IL-18 
into their corresponding processed entities (Perregaux and Gabel, 1994) through the 
purinergic P2X7 receptor (Falzoni et al., 1995; Ferrari et al., 1997). Abundant in 
haematopoietic cells (Collo et al., 1997; Ferrari et al., 2006), the P2X7 receptor is an ion 
channel gated by extracellular Adenosine Triphosphate (ATP) which generates an initial cation 
current on binding of the nucleotide (Surprenant et al., 1996) and has since been shown to 
link with the NLRP3 inflammasome (Mariathasan et al., 2004; Duncan et al., 2007). Low 
cytosolic K+ concentrations also initiate activation of NLRP1 (Petrilli et al., 2007), NLRC4 
(Arlehamn et al., 2010) and AIM2 (Petrilli et al., 2007; Fink et al., 2008; Muruve et al., 2008). 
Intriguingly, activation of caspase-1 by intracellular bacteria does not require ATP or 
intracellular K+ depletion (Franchi et al., 2007). A distinct second phase of the P2X7 ion 
current, indicative of large pore formation, is also observed in the presence of ATP (Di Virgilio, 
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1995; Falzoni et al., 1995; Surprenant et al., 1996) and in macrophages this pore activity has 
since been attributed to the pannexin-1 hemichannel associating with P2X7 (Pelegrin and 
Surprenant, 2006); the pannexin pore is the gateway exploited by microbes for the 
intracellular delivery of toxins and consequent inflammasome activation (Kanneganti et al., 
2007). Molecules involved in sterile inflammation are associated with transient ROS 
generation (Fubini and Hubbard, 2003). It is not clear how ROS trigger such activation but one 
proposed mechanism suggests that dissociation of constitutively-expressed thioredoxin-
interacting protein from thioredoxin allows the former to bind to the LRR domain of the 
inflammasome (Zhou et al., 2010). Another route of inflammasome activation by ROS is 
postulated as being due to Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidase 
(Nox) activity (Dostert et al., 2008). However, contradictory effects were reported in patients 
with chronic granulomatous disease who carry a mutation in the p22phox gene and in whom 
IL-1 secretion as a measure of inflammasome activity was Nox-independent (van Bruggen et 
al., 2010). A role for ROS signals emanating from damaged mitochondria has also been cited 
as a source of NLRP3 activation (Zhou et al., 2011) as well as NLRP3 oligomerization induced 
by the Mitochondrial Antiviral Signaling protein, MAVS (Park et al., 2013) and de-
ubiquitination of the inflammasome (Juliana et al., 2012). Sterile inflammation may also 
evoke inflammasome activation following damage by crystalline or particulate matter. Such 
compounds including alum, silica, asbestos, adjuvants and cholesterol (Duewell et al., 2010; 
Rajamaki et al., 2010) cause lysosomal disruption following their phagocytosis by 
macrophages. Consequently, lysosomal proteases such as cathepsin D are released into the 
cytosol and are then sensed by as yet unknown substrates triggering NLRP3 activation (Halle 
et al., 2008; Hornung et al., 2008). Use of a cathepsin B inhibitor partially impaired 
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inflammasome activation providing some support for the mechanism (Hornung et al., 2008); 
however, the possibility of off-target effects of these small molecules cannot be excluded.  
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                                                                                   CHAPTER TWO  
                 ASSESSMENT OF CHEMICAL-INDUCED CONTACT  
           HYPERSENSITIVITY: IN VIVO AND IN VITRO MODELS  
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The assessment of the skin sensitization potential of chemicals represents an important 
component of the safety assessment, relevant in the context of several EU regulations aiming 
at the protection of human health. Predictive testing to identify and characterize substances 
causing skin sensitization historically has been based on animal tests. Officially accepted 
animal test methods for skin sensitization potential assessment include the Buehler occluded 
patch test in the Guinea pig, the Guinea Pig Maximization Test by Magnusson & Kligman 
(GPMT) and the Mouse Local Lymph Node Assay (LLNA) with its non radioactive modifications 
(LLNA: DA and the LLNA: BrdU Elisa). The Organization for Economic Co-operation and 
Development (OECD) Test Guideline (TG) regulates all of these in vivo methods: TG406 for the 
GPMT and Buehler test; TG429 for the LLNA; TG442A and 442B for the LLNA: DA and the LLNA: 
BrdU Elisa respectively. Whereas the mouse LLNA measures the response provoked during 
the induction of sensitization, the two Guinea pig test measure challenge induced elicitation 
reactions in previously sensitized animals. The LLNA is considered a reduction and refinement 
method compared to the traditional Guinea pig tests. There has been a continuous effort to 
find alternative approaches, which avoid testing on animals wherever possible. Whenever 
replacement is not possible, the development of methods that use fewer animals or cause 
least harm to the animals is supported. The ‘Three Rs Principle’ (replacement, reduction and 
refinement of animal use) is present in all relevant EU legislations. In early 2003, the 7th 
amendment to the European Union’s Cosmetics Directive (76/768/EEC) was adopted, and 
according to it an immediate end to animal testing in the EU for cosmetic products and a 
complete ban of animal testing for ingredients by 11 March 2009. The animal testing ban was 
reinforced by a marketing ban on all cosmetic ingredients or products tested for the purposes 
of the Directive outside the EU after the same date. Since 11 July 2013 the new EU Regulation 
1223/2009 (Cosmetics Regulation) is in force, which prohibits the marketing of cosmetic 
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products, the final formulation, ingredients or combinations of ingredients, which have been 
tested on animals, and also prohibit each test currently, carried out using animals. 
 
Starting from the in vivo observation that in mouse IL-1α expression by KC was selectively 
increased after in vivo application of contact sensitizers but not tolerogen or irritant (Enk and 
Katz, 1992), similar results were reproduced in vitro using the murine KC cell line HEL30 
(Corsini et al., 1998). Same results were also obtained by Van Och et al (2005) and, 
furthermore, the authors observed that the ranking of potency was similar to the ranking 
established using the local lymph node assay. Similarly, using human KC it has been 
demonstrated that allergens but not irritants induced IL-12 (Muller et al., 1994; Corsini et al., 
1999). Trinitrobenzene sulphonic acid induced the expression of CD40 on KC, whereas Sodium 
Lauryl Sulfate (SLS) did not (Coutant et al., 1999). All together these studies indicate the 
possibility to identify contact sensitizer using murine or human KC. 
 
In the screening of new chemicals for human use, it should be very important both from safety 
and economic point of view to have biological markers to discriminate allergy and irritation 
events that have different impact on human health (Corsini and Roggen, 2009; dos Santos et 
al., 2009; Galbiati et al., 2010). 
 
On the other side, the EU Regulation on chemicals and their safe use, REACH, which came 
into force in 2007, gives greater responsibility to industry to manage the risks from chemicals 
and to provide safety information on the substances to allow safe handling. The REACH 
Regulation also calls for the progressive substitution of the most dangerous chemicals where 
possible.  
To achieve a complete replacement of animals in skin sensitization assessment, dose-
response information and evaluation of relative skin sensitizing potency to support effective 
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risk assessment are necessary. In this contest, potency is based on the concentration of 
chemicals needed to induce a positive response. While a number of methods, reflecting the 
major key events described in the OECD adverse outcome pathway for skin sensitization 
(OECD GD168), are at various stages of acceptance, validation, development and use, 
currently it is not possible to rank chemicals for their sensitizing potency, an issue that is 
important for a full safety assessment (Corsini et al., 2014). It is expected that a predictive 
method to totally replace animal testing will be in the form of a test battery comprising 
molecular, cell-based, and/or computational methods, the so-called “Integrated Approaches 
to Testing and Assessment (IATA)”. Currently available in vitro methods support the 
discrimination between skin sensitizers (i.e., UN GHS Category 1, where UN GHS stays for 
United Nations Globally Harmonized System of Classification and Labelling of Chemicals) and 
non-sensitizers in combination with other complementary information (i.e., in the context of 
an IATA). Depending on the regulatory framework, positive results may be used on their own 
to classify a chemical to UN GHS Category 1. They cannot, however, be used on their own to 
sub-categorize skin sensitizers into UN GHS subcategories 1A and 1B or to predict potency for 
safety assessment decisions, which is necessary to fully replace animal testing.  
A number of assays for the in vitro identification of contact and respiratory sensitization have 
been developed within the integrated European Framework Program 6 Project SENS-IT-IV. 
The aim of the SENS-IT-IV EU Frame Programme 6 funded integrated Project (LSHB-CT-2005-
018681) was to develop and optimize an integrated testing strategy consisting of in vitro 
human cell based assays, which will closely mimic sensitization mechanisms in vivo. These 
assays should provide an alternative approach to the LLNA. In vitro assays for risk assessment 
of potentially sensitizing substances can, once formally validated and implemented into 
European regulations, replace the LLNA (Kimber et al., 1990, 1991). In principle, a test system 
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comprised of KC alone may not be useful in establishing allergenic potential as these cells lack 
antigen-presenting capacity. However, in addition to chemical processing LC activation 
requires the binding of cytokines produced by KC as a result of initial chemical exposure. The 
irritant capacity of allergens might present an additional risk factor so that irritant allergens 
may be stronger allergens than non-irritant ones (Grabbe et al., 1996). In that case, the 
potency of chemicals to induce cutaneous sensitization may be assessed as a function of KC 
cytokine expression. 
Potency assessments is important as: (1) potency data are required for hazard classification 
and can lead to improvements in risk management; (2) potency data can facilitate risk 
assessment for skin sensitization. The evidence is that concentration of chemicals vary by up 
to four or five orders of magnitude with respect to their relative skin sensitizing potency 
(Jowsey et al., 2006).  
Based on the estimation of the concentration of chemical required to induce a stimulation 
index of three relative to concurrent vehicle-treated controls (EC3 value), the LLNA has 
proven very useful in assessing the skin sensitizing potency of chemicals: extreme, strong, 
moderate and weak were the categories proposed. In this scheme extreme sensitizers were 
defined as those having an EC3 value of less than 0.1%, strong= EC3 values of equal to or 
greater than 0.1% and less then 1%, moderate= EC3 values of equal to or greater than 1% and 
less that 10% and weak= EC3 values of equal to or greater than 10%. This scheme is 
summarized in Table 1. All the other chemicals, that are inactive in the LLNA and for which an 
EC3 value cannot be derived, should be classified as non-sensitizer. 
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CATEGORY EC3 VALUES (%) 
Extreme < 0.1 
Strong ≥ 0.1 - <1  
Moderate ≥ 1 - < 10 
Weak ≥10 - ≤ 100 
     
Table 1: categorization of contact allergens [8]  
Importantly, determinations of relative potency based on EC3 values appear to correlate 
closely with what is known of the relative ability of contact allergens to cause skin 
sensitization among human, by the human repeated insult patch test (HRIPT) (Basketter et 
al., 2000; Gerberick et al., 2001; Griem et al., 2003). 
A decision on collocation to a category was achieved using information from experimental 
human studies, specifically the HRIPT or the human maximization test (HMT) as published by 
Kligman (Kligman, 1989). Most data are able to offer a no-effect level (NOEL), and where 
multiple data exist, the highest value has been taken. For a few substances, a lowest-effect 
level (LOEL) has been calculated. To understand the potency categorization on the basis of 
human data, the criteria is provided in Table 2, where the skin sensitizers are distributed into 
6 potency categories: 
 
POTENCY  
CATEGORY 
HRIPT/HTM NOEL DIAGNOSTIC  
PACHT TEST DATA 
USE INFORMATION 
 Extreme < 25 µg/cm2 
 
< 3% in most dermatology clinics Probably low exposure concentration 
Strong 25-500 µg/cm2 < 1% in most dermatology clinics 
 
Lower use concentration may raise 
Moderate 500-2500 µg/cm2 Up to 1%in major dermatology 
clinics 
By 1 category; higher use concentration 
may drop a category 
Weak > 2500 µg/cm2 Less common/ frequent positive 
results than category 3 
By 1 category; higher use concentration 
may drop a category 
Very weak > 10000 µg/cm2 Rarely positive except in selected 
patients with eczema 
Possibly despite high use 
Non     
sensitizers 
negative An absence of positive despite 
testing in many clinics 
Use could be high or low 
 
Table 2. Outline of potency categorization guidance [9]  
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Here the key point is that larger NOEL values equate to lower skin sensitization potency. 
Where there are multiple values, the higher value should always be used. The converse 
argument would always apply to LOEL values, where the smaller value must be adopted. As 
always, the final decision on a category will have considered all of the available evidence. This 
includes diagnostic patch test data, where this exists, judged against the use volume 
information. Diagnostic patch test data can be taken from the clinical literature and from the 
Scientific Committee on Consumer Safety (SCCS) review. 
In the contest of alternative methods, four non-animal tests have been recently validated 
(Table 3):  
- Direct peptide reactivity assay (DPRA), which measures depletion of a cysteine-and a 
lysine-containing peptide in the presence of the test chemical (Gerberick et al., 2007); 
- The KeratinoSens assayTM, which his based on a luciferase reporter gene under the 
control of an anti-oxidant response element of the human AKR1C2 gene stably 
inserted into HaCaT keratinocytes (Emter et al. 2010);  
- The human cell line activation test (h-CLAT), addressing CD86 and CD54 upregulation 
in THP-1 cells (Sakaguchi et al., 2009);  
- and the IL-8 Luc assay, which measures the effects of chemicals on IL-8 promoter 
activity in the IL-8 reporter cell line THP-G8 cells (Kimura et al.,2015).  
 
The first three methods have been validated by European Union Reference Laboratory for 
alternatives to animal testing (EURL-ECVAM), while the last by Japanese Center for the 
Validation of Alternative Methods (JaCVAM).  
 
Placed in the context of the AOP, the DPRA evaluates key event 1: the protein/peptide  
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reactivity of a substance, the KeratinoSensTM represents key event 2 and gives a measure 
keratinocytes activation and h-CLAT, Myeloid U937 skin sensitization test (MUSST) and IL-8 
Luc assay describe key event 3, the dendritic cell activation. 
 
Test Guideline 
(TG)/ Methods 
Endpoint Data interpretation 
(OECD TG) 
Data interpretation for potency 
assessment 
 
 
TG 442C 
DPRA 
 
Cys/Lys peptide 
depletion (0-
100%) 
 
Depletion ≤ 6.38%: 
No Sensitizer 
Depletion > 6.38%: 
Sensitizer 
 
0% ≤ depletation ≤ 6.38%: minimal reactivity 
6.38% ≤ depletation ≤ 22.62%: low reactivity 
22.62% ≤ depletation ≤ 42.47%: moderate 
reactivity 
42.47% ≤ depletation ≤ 100%: high reactivity 
 
 
TG 442D 
KeratinoSens 
 
 
Luciferase gene 
induction 
(activation of 
Keap1-Nrf2-ARE 
pathways 
 
test chemical is 
sensitizer if: 
-Luciferase fold 
induction is higher than 
1.5 
-viability ≥ 70% 
 
 
dose-response data from 12 concentrations used 
to calculate EC1.5 and IC50 values. 
 
TG 442E 
h-CLAT 
 
 
Induction of 
CD86 and CD54 
 
test chemical is 
sensitizer if: 
-RFICD86 ≥ 150% and/or  
-RFICD54 ≥ 200% 
-viability ≥ 50% 
 
 
dose-response data from 8 concentrations used to 
calculate EC150 forCD86 and EC200 for CD54. 
- EC150 or EC200 ≤ 13 µg/ml: cat. 1A 
- EC150 or EC200 > 13 µg/ml: cat. 1B 
 
 
TG draft* 
U-SENSTM (MUSST) 
 
Induction of 
CD86 
 
test chemical is 
sensitizer if: 
-S.I.CD86 ≥ 150% (no 
interference from 
cytotoxicity, solubility) 
-viability ≥70% 
 
 
Minimum of 4 concentrations tested: 
- EC150≤ 40 µg/ml and CV70 ≤ 100 µg/ml: cat. 1A 
 
 
 
IL-8 Luc Assay 
 
Luciferase gene 
induction (IL-8 
and 
glycertaldehyde 
3-phosphate 
deydrogenase 
(GAPDH) 
expression 
 
 
test chemical is 
sensitizer if: 
FInSLO-LA ≥ 1.4 lower 
limit of the 95% CI of 
FInSLO ≥ 1.0 
 
 
11 concentrations tested 
correlation between EC 1.4 and EC3 values 
investigated (Takahashi et al., 2011). 
*http://www.altex.ch/resources/altex_2017_2_187_192_Editorial2.pdf 
Table 3. OECD adopted in chemico/in vitro methods [10]  
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DPRA 
The majority of skin sensitizers are electrophilic in nature, which underpin their ability to react 
with the nucleophilic aminoacids of proteins. This haptenation process is reproduced in vitro 
in the DPRA, which quantifies the amount of unbound peptides in the reaction mixture by 
High Performance Liquid Chromatography (HPLC) following the covalent bond formation 
between hapten and aminoacid residues in the peptide. When the mean peptide depletion 
of the cysteine and lysine peptides is greater than 6.38%, the chemical is judged as a sensitizer 
(Table 3). However, as the chemical reactivity varies markedly between various functional 
groups, the reaction rate of test chemicals with the DPRA peptide may not be linearly related 
to their in vivo sensitization potency, making the DPRA unsuitable for potency assessment. 
This is also collected in the OECD guideline, where the different DPRA classes of reactivity 
(i.e., low, moderate and high) are actually assigned a positive prediction, without any sub 
classification. In the DPRA non allergens and weak allergens demonstrated minimal to low 
peptide reactivity, whereas moderate to extremely potent allergens displayed moderate to 
high peptide reactivity (Gerbeich et al., 2007).  
 
The KeratinoSensTM 
The KeratinoSensTM assay is based on a luciferase reporter gene under the control of an anti-
oxidant response element (Nrf2) of the human AKR1C2 gene stably inserted into HaCaT KCs 
(Emter et al., 2010). It measures a cellular defense mechanism triggered by chemical allergen-
induced oxidative stress.  
For each chemical, the assay allows the calculation of the EC1.5, EC2 and EC3 (concentration 
in µM for 1.5, 2, and 3 fold induction of the luciferase activity and the IC50 (concentration in 
µM resulting in 50% reduction in cellular viability). A substance is considered to be a sensitizer 
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if an induction equal or exceeding 1.5-fold compared to the vehicle control is observed at a 
concentration below 1mM and at which cells remain >70% viable (Table 3). The correlation 
analysis of the individual parameters (logarithmic normalized) for the 244 chemicals against 
the EC3 in the LLNA gave a R2 (%) of 44.8% for EC2 and 33.5% for IC50, statistically significant 
but not impressive. Similar values were obtained when comparing in vitro results with human 
data (Natsch et al., 2015). While the assay can be useful for hazard identification and labeling, 
it cannot provide an estimation of the no induction sensitization level or the point of 
departure for skin sensitization. One of the limitations of all traditional cell cultures is that 
cells are grown in aqueous solutions, in which the intrinsic poor solubility of lipophilic 
substances or the instability of certain chemicals (i.e., anhydride) in water can affect the 
correct potency classification, resulting in a weak correlation. The other bottleneck of many 
in vitro methods, which may give false negative results, is the limited metabolic capacity of 
the cell lines used. The possibility to use reconstituted human epidermis to overcome these 
problems will be later discussed. 
 
h-CLAT 
The h-CLAT assay, developed by KAO and Shiseido, measures the selective induction of the 
surface markers CD54 and CD86 in the human promyelocytic cell line THP-1, which functions 
as a DC surrogate (Sakaguchi et al, 2009). A substance is considered a sensitizer if the relative 
fluorescence intensity (RFI) of CD86 and/or CD54 is greater than 150% or 200% at any tested 
dose in at least two out of three experiments. From dose response curves of the three 
experiments, the median concentration inducing 150% of CD86 RFI and/or 200% of CD54 RFI 
(EC150 or EC200) is calculated like the EC3 value in the LLNA (Table 3). The lower EC value 
obtained is considered the minimal induction threshold (MIT). Based on the MIT value, the h-
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CLAT can be used to score strong sensitizers if MIT < 10 µg/mL and weak if MIT = 10-5000 
µg/mL (Jaworska et al., 2015). The same limitations described for the KeratinoSensTM also 
apply to the h-CLAT. While the assay can be useful for hazard identification and labeling, it 
cannot provide an estimation of the no induction sensitization level or the point of departure 
for skin sensitization.  
 
U-SENSTM 
The U-SENS™ assay, developed by l’Oreal, known as MUSST (Myeloid U937 Skin Sensitization 
Test), is based on dendritic cell activation following exposure to sensitizers in the U937 human 
myeloid cell line by measuring the induction of the expression of CD86 by flow cytometry. A 
substance inducing an increase in CD86 protein expression of Stimulation Index (SI) 150% is 
considered to be a sensitizer (Table 3). The predictive performance of U-SENS™ was assessed 
via a comprehensive comparison analysis with the available human and LLNA data of 175 
substances. U-SENS™ showed 79% specificity, 90% sensitivity and 88% accuracy.  
 
IL-8 Luc Assay 
The assay, validates by JaCVAM, evaluates the effect of chemicals on IL-8 promoter activity in 
the IL-8 reporter cell line THP-G8 (Takahashi et al., 2011). It is a high throughput method for 
detection of IL-8 mRNA induction by sensitizers. With regards to potency, a rank classification 
is possible, with an accuracy of 70.9%, an over-prediction rate of 10.7% and an under 
prediction rate of 18.4% (Kimura et al., 2015). Also, this assay cannot provide an estimation 
of the no induction sensitization level or the point of departure for skin sensitization (Table 
3). 
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Besides the validated tests, there are several other methods at different stages of 
development and acceptance. Among them, of my particular interest was the RhE IL-18 
potency test (Gibbs et al., 2013), based on the use of reconstructed human epidermis.  
Currently, methods based on skin models are being explored to resolve sensitizing potency.  
These methods have several advantages over traditional cell cultures, and are expected to 
have broader applicability. Topical application in relevant vehicles (e.g., in the vehicle used in 
animal tests or in a cosmetic/dermatological formulation) is only possible in 3D models which 
mimic in vivo bio-availability of a chemical more closely, and which may therefore lead to 
improved assessment of sensitizer potency (Natsch et al., 2015).  
RhE IL-18 potency assay is based on the possibility of combining the epidermal equivalent 
potency assay, based on the irritation potential, with the assessment of IL-18 release to 
provide a single test for identification and classification of skin sensitizing chemicals, including 
chemicals of low water solubility or stability (Gibbs et al., 2013). A protocol was developed 
using different 3D-epidermal models including in house VUMC model, epiCS® (previously 
EST1000™, Cell Systems, Troisdorf, Germany), MatTek EpiDerm™ (MatTek In Vitro Life 
Science Laboratories, Bratislava, Slovak Republic) and SkinEthic™ (Episkin, Lyon, France) RhE. 
Following topical exposure for 24 h to contact allergens a robust increase in IL-18 release was 
observed only after exposure to contact allergens. Correlating the in vitro RhE sensitizer 
potency data, which assesses the chemical concentration which results in 50% cytotoxicity 
(EE-EC50) with human and animal data showed a superior correlation with human DSA05 
(induction dose per skin area, in µg/cm2, in a human repeat-insult patch test or human 
maximization test that produces a positive response in 5% of the tested population) data 
compared to LLNA data. Also, a good correlation was observed for release of IL-18 (SI-2) into 
culture supernatants with human DSA05 data. 
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Given the complexity of the biological mechanisms underlying the acquisition of skin 
sensitization it is proposed that, in the near future, no single non-animal test method will be 
able to replace the currently used regulatory animal tests, instead a combination of methods 
addressing key mechanisms of the sensitization AOP will be needed to achieve full 
replacement. 
In conclusion, the alternative methods able to discriminate between sensitizers and non-
sensitizers are already available. Therefore, it is clear that at the moment the more realistic 
way forward to fully replace animal testing seems to have as more as possible validated 
alternative methods (in vitro, in silico) covering the different biological key events of skin 
sensitization, and use them in an integrated testing strategy. 
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The aims of my PhD project were: 
 
1. To understand at the molecular level the mechanism of action underlying contact 
allergen-induced IL-18 production for a better understanding of the mechanisms 
defining potency. 
       Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction   
        of IL-18 in human keratinocytes 
                A. Papale, E. Kummer, V. Galbiati, M. Marinovich, C.L. Galli, E. Corsini 
 
NLRP12 protein and the NLRP3 inflammasome complex in the induction of IL-18 in human 
keratinocytes: further developments (manuscript in preparation) 
A. Papale, V. Viscardi, C. Lossani, N. Marchetti, V. Galbiati, E. Corsini 
 
2. To expand the list of chemicals tested to prove the validity of the RhE IL-18 assay not 
only for hazard identification but also for the estimation of the allergenic potency 
required for a full replacement of animals. 
Development of an in vitro method to estimate the sensitization induction level of contact allergens 
V. Galbiati, A. Papale, M. Marinovich, S. Gibbs, E. Roggen, E. Corsini 
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                                                                                CHAPTER FOUR 
               MATERIALS AND METHODS: BRIEFLY 
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Chemicals used for: 
- Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-
18 in human keratinocytes; 
 
- NLRP12 protein and the NLRP3 inflammasome complex in the induction of IL-18 in human 
keratinocytes: further developments (manuscript in preparation). 
 
The extreme skin sensitizer 2,4-Dinitrochlorobenzene (DNCB) (CAS #97-00-7) and the strong 
sensitizer PPD (CAS#106-50-3) were used. The use of both sensitizers is reported in materials 
and methods detail/chemicals section. For experiments using submerged keratinocytes NCTC 
2544 cell culture, DNCB and PPD were dissolved in dimethyl sulfoxide (DMSO), 0.2% final 
concentration in culture medium., while acetone/olive oil (AOO, 4:1) was used for experiments 
using RhE. Cell culture media and all supplements were from Sigma-Aldrich Co. (St. Louis, Mo, 
USA) at the highest purity available, while RhE and RhE medium (EPI-100-MM- 60) were from 
MatTek corporation (MatTek In Vitro Life Science Laboratories, Bratislava, Slovakia).  
 
Chemicals used for: 
- Development of an in vitro method to estimate the sensitization induction level of contact 
allergens. 
 
A total of 10 contact sensitizers and 4 non-sensitizers were studied. Chemicals were selected 
from the Interagency Coordinating Committee on the Validation of Alternative Methods 
(ICCVAM) database and the LLNA database of 341 chemicals (Gerberick et al., 2005; Kern et al., 
2010), and not previously tested in the RhE assay, namely benzoquinone, chloropromazine, 
chloramine T, benzyl salicylate, diethyl maleate, dihydroeugenol, benzyl cinnamate, 2,4-
dichloronitrobenzene, imidazolidinyl urea, and limonene as contact sensitizers while benzyl 
alcohol, isopropanol, dimethyl isophtalate and 4-aminobenzoic acid as non-sensitizers in the 
LLNA. The use of all sensitizers is reported in materials and methods detail/chemicals section. 
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Cell culture used for: 
- Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-
18 in human keratinocytes; 
 
- NLRP12 protein and the NLRP3 inflammasome complex in the induction of IL-18 in human 
keratinocytes: further developments (manuscript in preparation). 
 
For experiments the human KC cell line NCTC 2544 was used (Istituto Zooprofilattico, Brescia, 
Italia). Cells were seeded at a density of 2.5x105 cells/ml (for more information, see materials 
and methods detail/cell counting section) in RPMI 1640 containing 2 mM l-glutamine, 0.1 
mg/ml streptomycin, 100 IU/ml penicillin and 0.1% gentamycin, supplemented with 10% 
heated-inactivated fetal calf serum (media) and cultured at 37°C in 5% CO2. For IL-18 
production, cells were seeded in 24-well plates (0.5 ml/well). For NLRP12 and Blimp-1 mRNA 
expression and Western blot analysis, cells were seeded in 100 mm Petri dishes (10 ml/Petri). 
After o.n. adherence, cells were treated for different times 3, 6 and 24 h with DNCB (1.0, 1.5 
and 2 μg/ml), PPD (7.5, 15 and 30 μg/ml) or DMSO as vehicle control (0.2% final concentration 
in culture medium). Only for DNCB, additional time points were analyzed: 30 min, 1 and 2 h. 
For NLRP12 co-immunoprecipitation, cells were seeded in 100 mm Petri dishes (10 ml/Petri). 
After 24 h for PPD (30 μg/ml) and 3 h for DNCB (2 μg/ml) or DMSO as vehicle, the cellular 
pellets were lysed for co-immunoprecipitation experiments. 
 
Reconstituted human epidermis (RhE) used for: 
- Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-
18 in human keratinocytes. 
 
EpiDerm™ Skin Model (EPI-200) was used (the technology and the applications are described 
in materials and methods detail/EpiDerm™). RhE was maintained according to the supplier’s 
instructions at 37°C, 5% CO2 and 95% relative humidity.  
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Chemical exposure 
After 24 h of equilibration time, RhE was transfected with siNLRP12 and siBlimp-1 for 48 h 
(see small interference RNA section). RhE was then exposed to DNCB (1.5 mg/ml) or AOO as 
vehicle control. Finn Chamber filter paper disks were impregnated with DNCB and AOO and 
applied topically to the RhE stratum corneum for 24 h (Gibbs et al. 2013). Culture 
supernatants were harvested for IL-18 analysis by enzyme-linked immunosorbent assay 
(ELISA). 
 
Reconstituted human epidermis (RhE) used for: 
- Development of an in vitro method to estimate the sensitization induction level of contact 
allergens. 
 
RhE were exposed to described chemicals (Table 4). 
Chemical exposure 
The assay was performed in order to determine the EC50 value of the chemical (EC50 = 
effective chemical concentration required to reduce RhE metabolic activity corresponding to 
cell viability to 50% of the maximum value compared to vehicle exposed cultures) and the 
release of IL-18 associated with its treatment. According to the SOP (Gibbs et al., 2013; Teunis 
et al., 2013, 2014), the maximum solubility of chemical was first identified by dissolving the 
compound in different vehicles. Dilutions were made in the following order: 200, 100, 50, 25, 
12.5, 6.25, 3.12, 1.56, 0.78, 0.39, 0.20 and 0.10 mg/ml until a clear solution was reached. The 
vehicle with the highest dissolving capacity was chosen. Vehicles used are reported in the 
Table 4. 
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Chemical name In vitro vehicle 
Benzoquinone AOO 
Chlorpromazine Medium 
Chloramine T Medium 
Benzyl salicylate AOO 
Diethyl maleate AOO 
Dihydroeugenol AOO 
Benzyl cinnamate AOO 
2,4-Dichloronitrobenzene AOO 
Imidazolidinyl urea medium 
limonene AOO 
Benzyl alcohol AOO 
Isopropanol AOO 
Dimethyl isophthalate AOO 
4-aminobenzoic acid AOO 
 
Table 4. Chemicals and vehicles for RhE exprosure [11]  
 
Chemicals were then tested in dose-response experiments starting with the highest soluble 
concentration and decreasing with 2-fold serial dilutions for a total of five concentrations. 
Test chemicals stock solutions were freshly prepared in acetone:olive oil (4:1) or in medium. 
For exposure, Finn Chamber filter paper discs 8 mm (Epitest LTD Oy, Finland) were 
impregnated with chemicals or vehicle controls and applied topically to the RhE stratum 
corneum. Cultures were incubated with chemicals for 24 h. After chemical exposure, filter 
paper discs were removed and metabolic activity was determined immediately by the MTT 
assay, while culture supernatants were harvested and stored at 80°C for IL-18 quantification 
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by ELISA as described below. Chemicals were tested in single in two independent RhE batches. 
Control conditions (unexposed, vehicle(s) and positive control (DNCB 3 mg/ml in AOO)) were 
tested in double in each experiment.  
 
Viability used for: 
- Development of an in vitro method to estimate the sensitization induction level of contact 
allergens. 
 
The MTT and other assays used in the experiments are described in materials and methods 
detail/cell viability section. After 24 h exposure, filter paper discs were removed from RhE. 
The MTT analysis was performed in 24-well plates. Thiazolyl blue tetrazolium bromide (MTT) 
(Sigma-Aldrich) solution in PBS (0.5 ml/well of a 5 mg/ml solution) was added to the 24-well 
plate, RhE cultures were placed on top and further incubated for 2 h under standard culture 
conditions. Cultures were then transferred to a new 24-well plate containing 0.3 ml 
isopropanol to dissolve the formazan crystals. Plates were incubated overnight, sealed with 
parafilm and protected from the light at room temperature. The absorbance was measured 
at 595 nm and cell viability is expressed as a % relative to the absorbance value of vehicle 
control treated RhE. The RhE-EC50 values were obtained by linear regression analysis based 
on changes in metabolic activity (MTT).  
 
“Alternative” IL-18 ELISA used for: 
- Development of an in vitro method to estimate the sensitization induction level of contact 
allergens. 
 
We had developed an alternative IL-18 ELISA using antibodies not derived from ascites. In this 
case, ELISA plates were coated with capture antibody (Mouse anti-human IL-18-UNLB, 
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Southern Biotech, AL, USA) 0.1 mg/ml in PBS (dilution 1:5000, 100 ml/well) and incubated on 
at 4°C. After blocking for 1 h in 1% BSA in PBS, samples and standard curve (recombinant 
human IL-18, MBL International, MA, USA) were plated (100 ml/well) for 2 h at RT. After 
washing, rabbit anti IL-18 (MyBioSource, CA, USA) was added (dilution 1:1000 in blocking 
buffer – 100 ml/well) for 1 h at RT. After 1 h, a goat anti rabbit IgG-horseradish peroxidase 
conjugate (BIO-RAD, Segrate, Italy) was added (dilution 1:15.000 in blocking buffer, 100 
ml/well). After washing, the substrate solution (tetramethylbenzidine (TMB) liquid substrate, 
Sigma-Aldrich, MO, USA) was added (100 ml/well). Plates were read at 595 nm. Results were 
calculated in pg/ml from a standard curve and then converted to a SI, calculated as:  
IL-18 SI= IL-18 in chemical treated RhE/ IL-18 in vehicle treated RhE  
IL-18 SI2 values were obtained by linear regression analysis based on the chemical 
concentration resulting in a 2-fold increase in IL-18 release.  
 
Determination of interference of chemical with MTT assay and IL-18 ELISA 
If chemicals interfere with the readouts, they need to be excluded from the RhE IL-18 assay, 
following outside of the applicability domain of the assay. In order to determine whether a 
chemical interferes with the MTT assay, the highest soluble chemical concentration is 
incubated with the MTT solution in the absence of RhE. If a color change is observed, then 
the chemical must be excluded. To determine if a chemical interferes with the ELISA, a known 
amount of recombinant human IL-18 (e.g. 250 pg/ml) is spiked directly into conditioned 
media of RhE treated with the chemical suspected for interference. If the calculated 
concentration differs from the nominal concentration of IL-18, the chemical must be excluded 
from the RhE potency assay as it interferes with the ELISA.  
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IL-18 ELISA used for: 
- Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-
18 in human keratinocytes. 
 
For the assessment of IL-18 production in NCTC 2544 cells, monolayers were gently washed 
twice with 0.5 ml of phosphate-buffered saline (PBS) and lysed in 0.25 ml of 0.5% Triton X-
100 in PBS. Cell lysates were stored at -80°C until measurement. Intracellular IL-18 content 
was assessed by specific sandwich ELISA as described in materials and methods detail/IL-18 
ELISA (Galbiati and Corsini, 2012). Results were normalized by cellular protein content. The 
protein content of the cell lysate was measured using a commercially available kit 
(Bicinchoninic acid solution and Copper (II) sulfate solution, Sigma-Aldrich Co.) as described 
in materials and methods detail/total protein determination. Results are expressed as a 
stimulation index (SI), as described below. For the assessment of IL-18 release, culture 
supernatants were harvested and stored at -80 °C for IL-18 analysis by ELISA. For the 
assessment of IL-18 release in RhE, after chemical exposure, culture supernatants were 
harvested and stored at -80°C for IL-18 analysis by ELISA. 
Results were calculated in pg/ml from a standard curve and then converted to a SI, calculated 
as: 
IL-18 SI = IL-18 in chemical treated cells or RhE/ IL-18 in vehicle treated cells or RhE 
 
RNA isolation used for: 
- Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-
18 in human keratinocytes. 
 
For total Ribonucleic Acid (RNA) extraction, after treatment culture media was discarded, 
NCTC 2544 cells washed with PBS, and scraped in 5 ml of cold PBS, transferred in 14 ml 
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polypropylene tubes and centrifuged for 5 min at 1200 rpm at 5 °C. The supernatant was 
discarded, and cell pellets lysed with 1 ml of Tri-reagent (Sigma-Aldrich). For total RNA 
extraction on RhE, inserts were washed with PBS, lysed with 1 ml of Tri-reagent (Sigma-Aldrich 
Co.), homogenized for 20 sec at room temperature, snap-frozen twice, sonicated for 15 sec 
(50 Hz), and finally, centrifuged for 5 min at 15,000 rpm. Total RNA was extracted following 
as described in materials and methods detail/RNA extraction. 
 
Microarray and quantitative Polymerase Chain Reaction (qPCR) o Real-Time PCR used for: 
- Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-
18 in human keratinocytes. 
 
To identify genes involved in inflammasome activation, cells were treated for 6 h with PPD 30 
μg/ml or DMSO as vehicle control and total RNA extracted. After Retro Transcription (RT) 
(described in materials and methods detail/Retro Trascpription PCR), the inflammasome 
RT2 Profiler PCR Array from Qiagen (Hilden, Germany) was used following the supplier’s 
instructions (see materials and methods detail/PCR arrays). 
For the synthesis of cDNA, 2.0 μg of total RNA were retrotranscripted using a high-capacity 
cDNA reverse transcription kit from Applied Biosystems (Foster City, CA, USA), following the 
supplier’s instructions. For real-time PCR analysis, TaqMan-PCR technology was used. For 
each PCR, 10 ng of total RNA was used. The 18S ribosomal RNA was used as endogenous 
reference. Quantification of the transcripts was performed by the 2−ΔΔCT method (Livak and 
Schmittgen 2001), as described in methods detail/ quantitative PCR or Real-Time PCR. 
 
Small Interference RNA (siRNA) used for: 
- Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-
18 in human keratinocytes. 
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 The effect of inducing RNA interference on NLRP12 and Blimp-1 was performed using 
commercially available reagents (Qiagen) following manufacturer’s instructions (see methods 
detail/transfection and silencing). Briefly, cells were seeded 1.6 x105 cells/ml in 24-wells 
plates and after overnight adherence, transfection reagent, siNLRP12 (20 nM final 
concentration) and siBlimp-1 (40 nM final concentration) were added in RPMI 1640 
containing 2 mM l-glutamine, 0.1 mg/ml streptomycin, 100 IU/ml penicillin and 0.1% 
gentamycin to promote the silencing (48 h). After 4 h of incubation, fetal calf serum was 
added (10% final concentration). As control siRNA, a siRNA sequence that will not cause the 
specific degradation of any cellular message was used (Qiagen). RhE was transfected directly 
in Assay Medium (EPI- 100-ASY), supplied by MatTek corporation, with transfection reagent, 
siNLRP12 (60 nM final concentration) and siBlimp-1 (80 nM final concentration) to promote 
silencing. As control siRNA, a siRNA sequence that will not cause the specific degradation of 
any cellular message was used (from Qiagen). Silencing was conducted following 
manufacturer’s instructions. 48 hrs after siRNA transfection, NLRP12 and Blimp-1 contents in 
whole-cell lysate were assessed by WB using specific antibodies, to confirm the silencing of 
proteins. Cells were then treated with DNCB (2 μg/ml) and PPD (15 μg/ml), or DMSO as vehicle 
control, while RhE was treated with DNCB (1.5 mg/ml), or AOO as vehicle control for 24 h to 
assess IL-18 production. 
 
Western Blot (WB) used for: 
- Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-
18 in human keratinocytes; 
 
 - NLRP12 protein and the NLRP3 inflammasome complex in the induction of IL-18 in human 
keratinocytes: further developments (manuscript in preparation). 
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For WB analysis, after established time of incubation, culture media was discarded, cells 
washed with PBS, scraped in 5 ml of cold PBS, transferred in 14 ml polypropylene tubes and 
centrifuged for 5 min at 1200 rpm at 5°C. The supernatant was discarded, and cells lysed in 
100 μl of homogenization buffer (50 mM TRIS, 150 mM NaCl, 5 mM EDTA pH 7.5, 0.5% Triton 
X-100, 50 μM PMSF, 2 μg/mL aprotinin, 1 μg/mL pepstatin and 1 μg/mL leupeptin). Hundred 
microliters of sample buffer 2X (125 Mm Tris HCl pH 6.8, 4% SDS, 20% glycerol, bromophenol 
blue, 6% β-mercaptoethanol) were added and denatured for 10 min at 100°C. The protein 
content was assessed using a commercial kit (Bio-Rad, Hercules, CA, USA), as described in 
materials and methods detail/protein quantification. Forty micrograms of proteins were 
electrophoresed into a 10% sodium dodecyl sulfate (SDS)–polyacrylamide gel under reducing 
condition. The proteins were then transferred to polyvinylidene difluoride (PVDF) membrane 
(Amersham, Little Chalfont, UK). Proteins were visualized using mouse monoclonal anti-β-
actin Ab (clone AC-15, 42 kDa; 1:5000) from Sigma-Aldrich, rabbit polyclonal anti-NLRP12 Ab 
(95–100 kDa; 1:1000) from Tocris Bioscience (Avonmouth, Bristol, UK), rabbit monoclonal 
anti-Blimp-1/PRDF1 Ab (clone C14A4, 95–100 kDa; 1:500), rabbit monoclonal anti-NLRP3 
antibody (110 kDa; 1:500), rabbit monoclonal anti-TMS1 (ASC) antibody (22 kDa; 1:1000), 
rabbit monoclonal anti-caspase-1 antibody (the pro-caspase-1: 48 kDa and the activated 
subunit: 20 kDa) from Cell Signaling Technology (Danvers, MA, USA) as primary antibodies 
and developed using enhanced chemiluminescence (Bio-Rad). The image of the blots was 
acquired with the Molecular Imager Gel Doc XR (Bio-Rad). The optical density (OD) of the 
bands was calculated and analyzed by means of the Image Lab version 4.0.1. For more 
information about WB, see materials and methods detail/Western Blot. 
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Co-immunoprecipitation (Co-IP) used for: 
- NLRP12 protein and the NLRP3 inflammasome complex in the induction of IL-18 in human 
keratinocytes: further developments (manuscript in preparation). 
 
Two hundred microliters of proteins were incubated in RIA buffer 2X (pH 7.2) (400 mM NaCl, 
20 mM EDTA, 20 mM Na2HPO4, 1% Nonidet P-40 and 0.1% sodium dodecyl sulfate (SDS) with 
a polyclonal anti-NLRP12 antibody (95-100 kDa; 1:200) from Tocris Bioscience (Avonmouth, 
Bristol, UK) overnight at 4°C on a wheel. Protein A/G plus agarose beads (Santa Cruz 
Biotechnology) were added and incubation was continued for 2 h at 4 °C on the wheel. Beads 
were collected by gravity and washed in RIA buffer 1X containing 0.1% SDS four times. Sample 
buffer 1X was then added to the samples and the mixture was boiled for 10 min. Beads were 
collected by centrifugation and the supernatant was loaded onto an acrylamide gel for SDS-
PAGE. The proteins were then transferred to PVDF membrane and the immunoprecipitated 
protein NLRP12 was visualized usig rabbit polyclonal anti-NLRP12 antibody (100 kDa; 1:500) 
from LS Bio LifeSpan Bioscience, Inc (Saettle, Washington); NLRP3, ASC and Caspase-1 are 
used with the same dilution described in WB. For more information about the technique, see 
materials and methods detail/immunoprecipitation and co-immunoprecipitation. 
 
Data analysis of cell culture 
All experiments were repeated at least three times. Data are expressed as mean ± SEM. 
Statistical analysis was performed using InStat software version 3.0a (GraphPad Software, La 
Jolla, CA, USA). Statistical significance was determined by ANOVA followed by a multiple 
comparison test as indicated in the legends. Effects were designated significant at p<0.05. 
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Data analysis of RhE 
According to SOP (Gibbs et al., 2013; Teunis et al., 2013, 2014), all chemicals were tested in 
at least two independent experiments using different RhE batches. Data obtained in two 
independent experiments is presented. As results are incorporated into a prediction model, 
it is not feasible and not necessary to run stats on each independent experiment. The 
following readouts were used: (1) For the assessment of allergenicity (YES/NO): if the fold 
increase in intracellular IL-18 is 2.0 in at least one of the concentrations tested the chemical 
is classified as contact sensitizer (H317). In case the two experiments gave inconsistent results 
(e.g. one positive and one negative), a third experiment was done, and the majority was used 
for classification (e.g. if two positives and one negative, the classification will be contact 
allergen). (2) For potency assessment: the arithmetic means of the values obtained in the two 
experiments for both cytotoxicity (MTT assay) expressed as of EC50 and IL- 18 SI2 (chemical 
concentration resulting in 2 fold increases in IL-18 release) were considered. Statistical 
analysis was performed using GraphPad InStat version 3.0a for Macintosh (GraphPad 
Software, San Diego, CA, USA).  
EE potency assay: the EE EC50 value is the effective chemical concentration required to 
reduce metabolic activity (corresponding to cell viability) to 50% of the maximum value. The 
100% value for cell viability corresponds to the vehicle control (1% DMSO culture medium or 
AOO 4:1). EE EC50 values were obtained by linear regression analysis based on changes in 
metabolic activity (MTT). Statistical significances were determined by Kruskal– Wallis 
(nonparametric, one way ANOVA) using GraphPad Prism version 4.00 for Windows (GraphPad 
Software, San Diego, CA, USA). Differences were considered significant for p<0.05. 
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IL-18 potency assessment: IL-18 SI-2 and SI-5 values were obtained by linear regression 
analysis based on the chemical concentration resulting in a 2 fold or 5 fold release in IL-18. 
Statistical significances were determined by Kruskal–Wallis (nonparametric, one way anova) 
using GraphPad Prism version 4.00 for Windows (GraphPad Software, San Diego, CA, USA). 
Differences were considered significant for p<0.05. Correlations were determined by 
nonparametric two-tailed correlation Spearman Analyses using GraphPad Software, San 
Diego, CA, USA. 
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Chemicals  
Several chemicals were used to perform the experiments, classified as weak, moderate, 
strong and extreme sensitizers, based on their potency. By Toxinet databases, PubChem and 
European Chemical Agency (EChA) here are reported some information about them: 
2,4-Dinitrochlorobenzene or 1-chloro-2,4-dinitrobenzene (DNCB) is an extreme sensitizer. It 
has been used as an immunostimulant in several conditions including some forms of cancer, 
and in the treatment of alopecia and warts. It has also been investigated in HIV infection and 
leprosy. Moreover it is used as a reagent for the detection and determination of nicotinic acid, 
nicotinamide and other pyridine compounds. It is used in the manufacture of intermediates 
for the production of dyes and pesticides and explosives, as a reagent, and as an algicide. 
1,4-benzenediamine or para-Phenylenediamine (PPD) is a strong sensitizer that is an aniline 
derivate used as a hair and fur dye, photographic developer, in photochemical 
measurements, chemical intermediate in the manufacturing of dyes, antioxidants, rubber 
accelerators, and component of some temporary tattoos (“black henna”).  
1,4-benzoquinone is an extreme sensitizer used in topical skin lightening preparations. 1,4-
benzoquinone metabolites are used as photographic reducers and developers, antioxidants, 
stabilizers in paints, oils, and motor fuels, an antioxidant in fats and oils, and as a chemical 
intermediate and reagents.  
Chloropromazine is a strong sensitizer and it is used to treat a wide range of conditions 
including anxiety, behavioral problems, nause and vomiting, and schizophenia. These 
medications are neuroleptic agents that affect adrenergic and/or dopaminergic receptor 
sites, metabolic inhibition of oxidative phosphorilation, and the excitability of neuronal 
membranes. 
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Chloramine T is a strong sensitizer. Hypochlorite is produced by hydrolysis. Most household 
bleach solution contains 3% to 5% hypochlorite, while swimming pool disinfectans and 
industrial strenght cleaners may contain up to 20% hypochlorite. It is used as a biocide and 
mild disinfectant.  
Benzyl salicylate is a moderate sensitizer. It is a salicylic acid benzyl ester, a chemical 
compound most frequently used in cosmetics as a fragrance additive or UV light absorber. It 
appears as an almost colorless liquid with a mild odor described as very faint, sweet-floral, 
slightly balsamic by those who can smell it, but many people either can't smell it at all or, 
describe its smell as "musky". Trace impurities may have a significant influence on the odor. 
It occurs naturally in a variety of plants and plant extracts and is widely used in blends of 
fragrance materials. It is also used as a solvent for crystalline synthetic musk’s and as a 
component and fixative in floral perfumes such as carnation, jasmine, lilac, and wallflower. 
Diethyl maleate is a moderate sensitizer. it is used in many organic syntheses as a dienophile 
for diene synthesis. It is used as an additive and intermediate for plastics, pigments, 
pharmaceuticals, and agricultural products. It is also an intermediate for the production of 
paints, adhesives, and copolymers. 
Dihydroeugenol or 2-methoxy-4-propylphenol is a moderate sensitizer. It is a colorless to 
pale yellow liquid with a spicy odor and earthy taste. This substance is used in the following 
products: washing and cleaning products, biocides (e.g. disinfectants, pest control products), 
air care products, polishes and waxes, perfumes and fragrances and cosmetics and personal 
care products. Other release to the environment of this substance is likely to occur from: 
indoor use as processing aid and outdoors use as processing aid.  
Benzyl cinnamate is a weak sensitizer. It is a component of heavy oriental perfumes and as 
fixative. It’s used as a flavoring agent. 
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Imidazolidinyl urea is a weak allergen. It is an antimicrobial preservative used in cosmetics. It 
is chemically related to diazolidinyl urea which is used in the same way. Imidazolidinyl urea 
acts as a formaldehyde releaser. 
Limonene is a weak allergen and it is a monoterpene and volatile hydrocarbon which occurs 
naturally in some trees and bushes. It is the predominant monoterpene in citrus oil and widely 
used as a flavor and fragrance additives for food and household cleaning products and 
solvents. 
Benzyl alcohol is not classified as sensitizer in LLNA test. It is common preservative in 
parenteral medication. It is also used in perfumes and flavors, as a bacteriostatic or viricidal 
agent in cosmetic, ointments, emulsions, and lotions, as a photographic developer for films 
and lithography, and as a dye for textiles, nylon carpets and sheet plastics. 
Isopropanol is not classified as sensitizer in LLNA test. Primarily used as a topical antiseptic. 
Typical household preparation contains 70% isopropanol. It is also used as a solvent in many 
household, cosmetic, and topical pharmaceutical products. Isopropanol baths are 
occasionally used in some cultural practices to relieve fevers. 
Dimethyl isophthalate is not classified as sensitizer in LLNA test. It is a plasticizer, it is a 
component of polyester resins, and perfume fixative. 
4-aminobenzoic acid or para-aminobenzoic acid (PABA) is not classified as sensitizer in LLNA 
test. PABA and its esters are ingredients in sunscreens. PABA is available in some health food 
stores, but it is not considered an essential nutrient. PABA has been used in the treatment of 
peyronie’s disease and various rickettsial diseases. The aminoalkyl esters of PABA are local 
anesthetics such as benzocaine and butesin. 
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Cell counting methods 
A key step in experimental studies involves the counting of cells or their density. Counting 
cells can be done in a number of ways, but in our experiments we used the manual cell 
counting, the hemocytometer (or hemacytometer/haemocytometer), Hemo, for blood; cyto, 
for cell; meter, for measuring: measuring blood cells (Fig. 8). When the hemocytometer was 
invented, Louis-Charles Malassez was trying to count blood cells.  
 
Fig. 8 The house Neubauer chamber or hemocytometer [12] 
The cover glass, which is placed on the sample, does not simply float on the suspension, but 
is held in place at a specified height (usually 0.1mm). Additionally, a grid is etched into the 
glass of the hemocytometer. This grid, an arrangement of squares of different sizes, allows 
for an easy counting of cells. This way it is possible to determine the number of cells in a 
specified volume. 
10 μL of count solution are introduced by capillarity in the space between the slide and the 
hemocytometer. It is possible to count the cells by the microscope. The Fig. 9 represents what 
it is possible to see under the microscope: the first small square of the top, a big square in the 
middle of your field of view: 
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Fig. 9 hemacytometer squares [13] 
 
Once get the cell numbers in the first square as in Fig. 9, it is possible to count the cells in the 
second. If the cells are counted on the top and right sides but not on the bottom and left sides 
of the first square, it needs to do the same thing with the second one. It is possible to take 
the average, as reported below: 
Take the average of cells per big square 1+2+3+4 (Fig.9) and divided by the total number of 
squares, multiply it by the dilution factor (x 105).  With the measured cell density obtained, it 
is possible to calculate how much more medium it is necessary to reach the recommended 
cell density, for NCTC 2544 cell line is 2.5 x 105. 
Final Volume= recommended cell density x initial volume/ measured cell density. 
 
EpiDerm™ 
EpiDerm™, patented by MatTek corporation, is a proven in vitro model system for chemical, 
pharmaceutical and skin care product testing, used in multiple ECVAM validations and OECD 
accepted test guidelines.  
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Fig. 10 RhE on left, tissue culture insert on right [14] 
 
Also known generically as a Reconstructed human Epidermis (RhE), EpiDerm™ is a ready-to-
use, highly differentiated 3D tissue model consisting of normal, human-derived epidermal 
keratinocytes (NHEK) cultured on specially prepared tissue culture inserts (Fig. 10). 
Cultured at the air-liquid interface (ALI), EpiDerm™ allows for the evaluation of topically 
applied compounds, chemicals, cosmetic/personal care product ingredients and final 
formulations. EpiDerm™ is the gold standard for a broad range of highly predictive in vitro 
applications. EpiDerm™ exhibits human epidermal tissue structure and cellular morphology 
with greater uniformity and reproducibility. It is 3D structure consisting of organized and 
proliferative basal cells, spinous and granular layers, and cornified epidermal layers are 
mitotically and metabolically active. 
The EpiDerm™ 3D human tissue model is used across a diverse range of applications including 
safety and risk assessment, and biological efficacy. With ALI culture technology, EpiDerm™ 
can be used to evaluate biological responses to topical applications of formulations or 
ingredients. It is possible to use EpiDerm™ to determine the skin irritation potential of liquids, 
solids, gels, lotions, ointments or creams; to determine the skin corrosion potential of test 
materials; to measure the electrical impedance of EpiDerm™ to assess the efficacy of topically 
applied moisturizers including creams, gels and lotions; to utilize existing transdermal 
permeation equipment or MatTek’s simple single insert permeation devices to assess API 
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permeation and flux to determine relative safety with the EpiDerm™ MTT ET-50 assay; to 
identify phototoxic effects of topical or systemic test substances using the EpiDerm™ 
Phototoxicity Assay (pre-validated); to identify genotoxic effects of topical or systemic test 
substances using EpiDerm™ Genotoxicity Assays (pre-validated); to evaluate active 
compounds for effects on epidermal differentiation using the under-developed EpiDerm™ 
tissue model. 
 
Cell viability 
Cell viability and cytotoxicity assays are used for drug screening and cytotoxicity tests of 
chemicals. They are based on various cell functions such as enzyme activity, cell membrane 
permeability, cell adherence, ATP production, co-enzyme production, and nucleotide uptake 
activity. Many have established methods such as Colony Formation method, Crystal Violet 
method, Tritium-Labeled Thymidine Uptake method, MTT, and WST methods, which are used 
for counting the number of live cells. Here are described the used tests during my studies: 
Trypan Blue is a widely used assay for staining dead cells. Trypan blue is a vital stain used to 
selectively color dead tissues or cells blue. It is a diazo dye. Live cells or tissues with intact cell 
membranes are not colored. Since cells are very selective in the compounds that pass through 
the membrane, in a viable cell trypan blue is not absorbed; however, it traverses the 
membrane in a dead cell. Hence, dead cells are shown as a distinctive blue color under a 
microscope. In this method, cell viability must be determined by counting the unstained cells 
with a microscope. However, Trypan Blue staining cannot be used to distinguish between the 
healthy cells and the cells that are alive but losing cell functions.  
Cellular enzymes such as lactate dehydrogenase (LDH) are used to evaluate cytotoxicity. 
When the cell membranes are compromised or damaged in any way, LDH, a soluble yet stable 
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enzyme found inside every living cell, is released into the surrounding extracellular space. 
Since this only happens when cell membrane integrity is compromised, the presence of this 
enzyme in the culture medium can be used as a cell death marker. The relative amounts of 
live and dead cells within the medium can then be quantified by measuring the amount of 
released LDH, using a LDH cytotoxicity assay. When using an LDH colorimetric assay, the 
amount of LDH released in the surrounding environment is measured with an enzymatic 
reaction, which converts iodonitrotetrazolium or INT (a tetrazolium salt) into a red color 
formazan. When LDH is present in the cell culture, it reduces NAD+ to NADH and H+ through 
the oxidation of lactate to pyruvate. Afterward, the catalyst (diaphorase) then transfers 
H/H+ from NADH + H+ to the tetrazolium salt INT to form the red colored formazan salt. The 
amount of color produced is measured at 490 nm by standard spectroscopy and is 
proportional to the amount of damaged cells in the culture. 
The colorimetric LDH cytotoxicity assay can also be used with different cell types for chemical-
mediated cytotoxicity and is ideal for supernatants from cells in culture. I performed LDH test 
on RhE medium to prove the cytotoxicity of a specific chemicals. 
Among the enzyme-based assays, the MTT assay is the best known method for determining 
mitochondrial dehydrogenase activities in the living cells. In the method, MTT, a yellow 
tetrazole, is reduced to a purple formazan by NADH. However, MTT formazan is insoluble in 
water, and it forms purple needle-shaped crystals in the cells. Therefore prior to measuring 
the absorbance, an organic solvent is required to solubilize the crystals. The absorbance of 
this colored solution can be quantified by measuring at a certain wavelength (usually 
between 500 and 600 nm) by a spectrophotometer. 
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ELISA Test  
ELISA is a biochemical technique used mainly in immunology to detect the presence of an 
antibody or an antigen in a sample.  
This method is based upon consecutive incubation steps with different antibodies and the 
samples of interest, resulting in the visualization via a substrate reaction of the amount of 
proteins present in the cell lysates (in this case, IL-18). In Fig. 11 each step is described: 
initially, the ELISA plate is coated with a coating antibody directed against IL-18 epitope(s). To 
avoid non-specific binding of the antibodies, a blocking step is performed. The samples 
(antigens) are subsequently added to the plate for incubation, along with a IL-18 standard 
curve, elsewhere on the plate. During this incubation step the IL-18 protein, present in 
supernatant, binds to the coating antibody. Unbound protein is washed away and the IL-18 
protein is detected with an IL-18 specific biotinylated detection antibody. Incubation with 
streptavidine-horseradish peroxidase (HRP) will allow binding to the biotine and a subsequent 
last step is the incubation with the TMB (3,3',5,5'-Tetramethylbenzidine) substrate. TMB 
produces a deep blue color during the enzymatic degradation of H2O2 by HRP. OD can be read 
at 595 or 655 nm, the substrate reaction should be stopped through addition of sulphuric acid 
(stop solution), changing the deep blue color into a clear yellow color. The absorbance is then 
read at 450 nm.  
     
 
 
Fig. 11 Sandwich ELISA platform overview [15], on the right house 96-well plate [16] 
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Total protein determination 
The protein determination of the samples must be performed parallel to ELISA IL-18, because 
the results of ELISA IL-18 describe the production of IL-18 in cell lysates samples and the 
protein quantity in each sample must be subtract. Total protein content of the cell lysates is 
determined by the bicinchoninic acid (BCA) methods. The BCA assay, is 
a biochemical assay for determining the total concentration of protein in a solution, similar 
to Lowry protein assay, Bradford protein assay or biuret reagent. The total protein 
concentration is exhibited by a color change of the sample solution from green to purple in 
proportion to protein concentration, which can then be measured 
using colorimetric techniques. The BCA assay primarily relies on two reactions. 
First, the peptide bonds in protein reduce Cu2+ ions from the copper(II) sulfate to Cu+ (a 
temperature dependent reaction). The amount of Cu2+ reduced is proportional to the amount 
of protein present in the solution. Next, two molecules of bicinchoninic acid chelate with each 
Cu+ ion, forming a purple-colored complex that strongly absorbs light at a wavelength of 
562 nm.  
The amount of protein present in a solution can be quantified by measuring the absorption 
spectra and comparing these data with protein solutions of known concentration. During my 
experiments a standard curve was used, considering the lowest point (white) and the highest 
point of the curve (1 mg/ml of BSA) with other intermediate concentrations: 0.04, 0.1, 0.2, 
0.4, 0.6, 0.8 mg/ml. 
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RNA extraction 
RNA extraction was performed by trizol (also known as Tri reagent) for the isolation of total 
RNA. This procedure is complicated by the ubiquitous presence of ribonuclease enzymes in 
cells and tissues, which can rapidly degrade RNA (Peirson et al., 2007). Trizol is a mixture of 
guanidine thioacyanate and phenol, which effectively dissolves DNA, RNA and protein on 
homogenization or lysis of tissue sample. After adding chloroform and centrifuging, the 
mixture separates into 3 phases with the upper clear aqueous phase containing the RNA, as 
in Fig. 12.  
 
 
 
Fig. 12 Phases of RNA extraction [17]  
 
The next steps in the extraction are washes and precipitation of the RNA. Moreover, there 
are commercial kits that enable simple RNA extractions, usually using a column that binds the 
RNA. At the end of extraction, RNA concentration of each samples is revealed by NanoDrop™ 
spectrophotometer. It is common for nucleic acid samples to be contaminated with other 
molecules (i.e. proteins, organic compounds, other). In table 5 are reported the potential 
contamination factors: they are described by two values, the 260 nm and 280 nm ratio 
(A260/280), and 260nm and 230 nm ratio (260/230). Pure RNA has an A260/A280 ratio of 2.0;  
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the A260/230 ratio is used as a secondary measure of nucleic acid purity. The A260/A230 ratio 
values for pure samples are often higher than the respective A260/A280 ratio values. As a 
guideline, the A260/A230 ratio should be greater than 1.5, ideally close to 1.8.   
 
 
Table 5. Table of potential contamination factors [18]  
 
Agarose gel 
The overall quality of an RNA preparation may be assessed by electrophoresis on a denaturing 
agarose gel; this will also give some information about RNA yield. A denaturing gel system is 
suggested because most RNA forms extensive secondary structure via intramolecular base 
pairing, and this prevents it from migrating strictly according to its size. Ethidium bromide was 
added to visualize the gel on a UV transilluminator. In my experiments, it was loaded 1 μg of 
total RNA. At the end of electrophoresis it was possible to analyze the quality of RNA by 
Quantity one program and to print the image of RNA separation, as in Fig. 13, to understand 
if it is intact or degraded.  
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Fig. 13 Intact vs. Degraded RNA on left side [19]; house RNA on right side [20] 
 
 
In Fig. 13 intact total RNA run on a denaturing gel will have sharp 28 Svedberg (28S) and 18S 
rRNA bands (eukaryotic samples). The 18S and 28S ribosomal RNA bands are clearly visible in 
the intact RNA sample. The degraded RNA appears as a lower molecular weight smear.  
 
Retro Transcription PCR (RT-PCR) 
RT-PCR is the synthesis of complementary DeoxyriboNucleic Acid (cDNA) from RNA 
templates. This process is catalyzed by the reverse transcriptase enzyme (RTase), which is the 
replicating enzyme of retroviruses. Reverse transcriptase was discovered in 1970, and since 
then, it has played an instrumental role in the advancement of molecular biology and 
biotechnology research. In the presence of all four deoxynucleotide triphosphates (dNTP: 
dATP, dCTP, dGTP, and dTTP) and under well-defined salt and pH conditions, the reverse 
transcriptase extends a primer complementary to the RNA to produce a cDNA for the RNA 
template (Fig. 14). RT-PCR is one of many variants of PCR. 
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Fig. 14 RT-PCR. [21]  
Polymerase Chain Reaction (PCR) 
PCR is a revolutionary method developed by Kary Mullis in the 1980s. PCR is based on using 
the ability of DNA polymerase to synthesize new strand of DNA complementary to the offered 
template strand. Because DNA polymerase can add a nucleotide only onto a preexisting 3'-
OH group, it needs a primer to which it can add the first nucleotide. This requirement makes 
it possible to delineate a specific region of template sequence that the researcher wants to 
amplify. At the end of the PCR reaction, the specific sequence will be accumulated in billions 
of copies (amplicons). Components of PCR are:  
 
- DNA template, the sample DNA that contains the target sequence. At the beginning 
of the reaction, high temperature is applied to the original double-stranded DNA 
molecule to separate the strands from each other.  
- DNA polymerase: a type of enzyme that synthesizes new strands of DNA 
complementary to the target sequence. The first and most commonly used of these 
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enzymes is Taq DNA polymerase (from Thermis aquaticus), whereas Pfu DNA 
polymerase (from Pyrococcus furiosus) is used widely because of its higher fidelity 
when copying DNA. Although these enzymes are subtly different, they both have two 
capabilities that make them suitable for PCR: 1) they can generate new strands of DNA 
using a DNA template and primers, and 2) they are heat resistant.  
- Primers: short pieces of single-stranded DNA those are complementary to the target 
sequence. The polymerase begins synthesizing new DNA from the end of the primer.  
- Nucleotides (dNTPs or deoxynucleotide triphosphates): single units of the bases A, T, 
G, and C, which are essentially "building blocks" for new DNA strands. 
 
Typically, PCR consists of a series of 20-40 repeated temperature changes, called cycles, with 
each cycle commonly consisting of two or three discrete temperature steps (Fig. 15). The 
cycling is often preceded by a single temperature step at a very high temperature (>90 °C), 
and followed by one hold at the end for final product extension or brief storage. The 
temperatures used and the length of time they are applied in each cycle depend on a variety 
of parameters, including the enzyme used for DNA synthesis, the concentration of bivalent 
ions and dNTPs in the reaction, and the melting temperature (Tm) of the primers (Rychlik W 
et al., 1990).  
  79 
 
Fig. 15 PCR steps [22]  
 
The individual steps common to most PCR methods are as follows: 
- Initialization: This step is only required for DNA polymerases that require heat 
activation by hot-start PCR (Sharkey, 1994). It consists of heating the reaction 
chamber to a temperature of 94-96°C, or 98°C 
- Denaturation: This step is the first regular cycling event and consists of heating the 
reaction chamber to 94-98°C for 20-30 sec. This causes DNA melting, or denaturation, 
of the double-stranded DNA template by breaking the hydrogen bonds between 
complementary bases, yielding two single-stranded DNA molecules. 
- Annealing: The reaction temperature is lowered to 50-65°C for 20-40 seconds, 
allowing annealing of the primers to each of the single-stranded DNA templates. Two 
different primers are typically included in the reaction mixture: one for each of the 
two single-stranded complements containing the target region. The primers are 
single-stranded sequences themselves, but are much shorter than the length of the 
target region, complementing only very short sequences at the 3' end of each strand. 
  80 
It is critical to determine a proper temperature for the annealing step because 
efficiency and specificity are strongly affected by the annealing temperature. This 
temperature must be low enough to allow for hybridization of the primer to the 
strand, but high enough for the hybridization to be specific, i.e., the primer should 
bind only to a perfectly complementary part of the strand, and nowhere else. If the 
temperature is too low, the primer may bind imperfectly. If it is too high, the primer 
may not bind at all. A typical annealing temperature is about 3-5°C below the Tm of 
the primers used. Stable hydrogen bonds between complementary bases are formed 
only when the primer sequence very closely matches the template sequence. During 
this step, the polymerase binds to the primer-template hybrid and begins DNA 
formation. 
- Extension/elongation: The temperature at this step depends on the DNA polymerase 
used; the optimum activity temperature for Taq polymerase is approximately 75-
80°C, though a temperature of 72°C is commonly used with this enzyme. In this step, 
the DNA polymerase synthesizes a new DNA strand complementary to the DNA 
template strand by adding free dNTPs from the reaction mixture that are 
complementary to the template in the 5'-to-3' direction, condensing the 5'-phosphate 
group of the dNTPs with the 3'-hydroxy group at the end of the nascent (elongating) 
DNA strand. The precise time required for elongation depends both on the DNA 
polymerase used and on the length of the DNA target region to amplify. As a rule of 
thumb, at their optimal temperature, most DNA polymerases polymerize a thousand 
bases per minute. Under optimal conditions (i.e., if there are no limitations due to 
limiting substrates or reagents), at each extension/elongation step, the number of 
DNA target sequences is doubled. With each successive cycle, the original template 
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strands plus all newly generated strands become template strands for the next round 
of elongation, leading to exponential (geometric) amplification of the specific DNA 
target region. 
The processes of denaturation, annealing and elongation constitute a single cycle. 
Multiple cycles are required to amplify the DNA target to millions of copies. The 
formula used to calculate the number of DNA copies formed after a given number of 
cycles is 2n, where n is the number of cycles. Thus, a reaction set for 30 cycles results 
in 230, or 1073741824, copies of the original double-stranded DNA target region. 
 Final elongation: This single step is optional, but is performed at a temperature of 
70-74°C (the temperature range required for optimal activity of most 
polymerases used in PCR) for 5-15 min after the last PCR cycle to ensure that any 
remaining single-stranded DNA is fully elongated. 
 Final hold: The final step cools the reaction chamber to 4-15°C for an indefinite 
time, and may be employed for short-term storage of the PCR products. 
 
PCR arrays 
RT² Profiler™ PCR Arrays are the most reliable and sensitive gene expression profiling real-
time PCR technology for analyzing a focused panel of genes involved in a signal transduction, 
biological process, or disease-related pathway. RT² Profiler PCR Arrays have gained popularity 
in the research of cancer, immunology, stem cells, toxicology, biomarker discovery and 
validation, and phenotypic analysis of cells and transgenic animals. In my experience, it was 
used Inflammasome PCR array PAHS-097Z to study down and up regulated genes involved in 
the inflammasome pathway and it was used a 96-well plate, where in each well lyophilized 
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primers are present to amplify a specific gene (Fig. 16). Moreover, in some plate, some wells 
are used to host housekeeping genes, genomic DNA control, Reverse transcription controls 
and positive PCR controls. 
 
Fig. 16 Schematic representation of a common 96-well plate RT² Profiler PCR array [23]  
 
The PCR array performs gene expression analysis with real-time PCR sensitivity and the multi-
gene profiling capability of a microarray. It was mixed the cDNA template with the 
appropriate ready-to-use PCR master mix, aliquotated equal volumes to each well and then 
run the Real-Time PCR program. 
 
qPCR or Real-Time PCR 
qPCR or Real-Time PCR method was invented by Heid et al., 1996. The method detects the 
increasing amount of template while the amplification is still progressing. Real-time qPCR has 
been used in a growing number of research applications including gene expression 
quantification. qPCR uses two basic quantification methods which are increasingly used and 
suitable for different applications: Absolute quantification and relative quantification. 
Absolute quantification is used to determine the absolute/exact quantity of a genomic DNA 
or RNA template within an unknown sample by using a standard curve that is prepared form 
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a dilution series of control template of known concentration. Relative quantification is used 
to measure the relative concentration of template (or target gene) in unknown samples 
normalized to a stably expressed reference gene, and compared relatively to a calibrator 
sample (for example time zero, or untreated sample). Real-time PCR uses several different 
fluorescence detection technologies (probe) to detect PCR products. One of them is SYBR 
Green, which is used as a dye for the quantification of double stranded DNA (dsDNA) PCR 
products. This fluorescent dye must be added in the reaction mixture, which contains 
template cDNA (or genomic DNA), gene specific primers (forward and reverse), and buffer. 
After annealing of the primers, a few dye molecules bind to the double stranded DNA, 
resulting in a significant increase of molecules to emit light upon excitation. With each cycle, 
more and more dye molecules bind with newly synthesized DNA. If the reaction is monitored 
continuously, an increase of fluorescence can be viewed by using a computer. Another 
detection technologies to detect PCR products is Taqman, that is used in my experiment. In 
Fig. 17 TaqMan hydrolysis principle is showed.    
 
Fig. 17 TaqMan probe mechanism [24]  
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1. At the start of real-time PCR, the temperature is raised to denature the double-
stranded cDNA. During this step, the signal from the fluorescent dye on the 5' end of 
the TaqMan probe is quenched by the nonfluorescent quencer on the 3' end. 
2. In the next step, the reaction temperature is lowered to allow the primers and probe 
to anneal to their specific target sequences. 
3. Taq DNA polymerase synthesizes new strands using the unlabeled primers and the 
template. When the polymerase reaches a TaqMan probe, its endogenous 5' nuclease 
activity cleaves the probe, separating the dye from the quencher. The 5'-nuclease 
activity of thermostable polymerases used in the polymerase chain reaction (PCR) 
cleaves hydrolysis probes during the amplicon extension step, which separates the 
detectable reporter fluorophore (R) from a quencher (Q). Fluorescence emitted when 
excited by an external light source (h ) at each PCR cycle is proportional to the amount 
of product formed. 
A PCR has three phases, exponential phase, linear phase and plateau phase as shown in 
Fig. 18 a, the exponential phase is the earliest segment in the PCR, in which product 
increases exponentially since the reagents are not limited. The linear phase is 
characterized by a linear increase in product as PCR reagents become limited. The PCR 
will eventually reach the plateau phase during later cycles and the amount of product will 
not change because some reagents become depleted. Real-time PCR exploits the fact that 
the quantity of PCR products in exponential phase is in proportion to the quantity of initial 
template under ideal conditions (Heid et al., 1996; Gibson et al., 1996). During the 
exponential phase PCR product will ideally double during each cycle if efficiency is perfect, 
i.e. 100%. It is possible to make the PCR amplification efficiency close to 100% in the 
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exponential phases if the PCR conditions, primer characteristics, template purity, and 
amplicon lengths are optimal. 
 
Fig. 18 Real-Time PCR [25]  
As shown in Fig. 18 b and c, the plot of logarithm 2-based transformed fluorescence signal 
versus cycle number will yield a linear range at which logarithm of fluorescence signal 
correlates with the original template amount. A baseline and a threshold can then be set for 
further analysis. The cycle number at the threshold level of log-based fluorescence is defined 
as Ct number, which is the observed value in most real-time PCR experiments. Since relative 
quantification is the goal for most for real-time PCR experiments, several data analysis 
procedures have been developed. In our experiments we used mathematical model ΔΔCt 
model (Livak et al., 2001). In the following model, the experiment will involve a control sample  
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and a treatment sample. For each sample, a target gene and a reference gene (18S) for 
internal control are included for PCR amplification. Typically several replicates (in my 
experiment, 2) are used for each sample to derive amplification efficiency. The efficiency-
calibrated model is a more generalized ΔΔCt model. Ct number is first plotted against cDNA 
input (or logarithm cDNA input), and the slope of the plot is calculated to determine the 
amplification efficiency (E). ΔCt for each gene (target or reference) is then calculated by 
subtracting the Ct number of target sample from that of control sample. As shown in 
Equation 1, the ratio of target gene expression in treatment versus control can be derived 
from the ratio between target gene efficiency (Etarget) to the power of target ΔCt (ΔCttarget) and 
reference gene efficiency (Ereference) to the power of reference ΔCt (ΔCtreference). The ΔΔCt 
model can be derived from the efficiency-calibrated model, if both target and reference genes 
reach their highest PCR amplification efficiency. In this circumstance, both target efficiency 
(Etarget) and control efficiency (Econtrol) equals 2, indicating amplicon doubling during each 
cycle, then there would be the same expression ratio derived from 2-ΔΔCt (Pfaffl, 2001; Livak 
et al., 2001). 
Ratio= (Ettarget)ΔCttarget (Ereference)ΔCtreference Equation1 
Whereas ΔCttarget= Ct control - Ct treatment and ΔCt reference = Ct control - Ct treatment 
Ratio = 2-ΔΔCt Equation 2 
Whereas ΔΔCt = ΔCt reference - ΔCtt arget 
Transfection and Silencing  
Transfection is a procedure that introduces foreign nucleic acids into cells to produce 
genetically modified cells. The transfection methods are broadly classified into three groups;  
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biological, chemical, and physical. These methods have advanced to make it possible to 
deliver nucleic acids to specific subcellular regions of cells. Transfection is a powerful 
analytical tool for study of gene function and regulation and protein function. The introduced 
genetic materials (DNAs and RNAs) exist in cells either stably or transiently depending on the 
nature of the genetic materials (Recillas-Targa, 2006). For stable transfection, introduced 
genetic materials that usually have a marker gene for selection (transgenes) are integrated 
into the host genome and sustain transgene expression even after host cells replicate (Glover 
et al., 2005). In contrast with stably transfected genes, transiently transfected genes are only 
expressed for a limited period of time and are not integrated into the genome (Recillas-Targa, 
2006). Transiently transfected genetic materials can be lost by environmental factors and cell 
division, so the choice of stable or transient transfection depends on the objective of the 
experiment. The main purpose of transfection is to study the function of genes or gene 
products, by enhancing or inhibiting specific gene expression in cells, and to produce 
recombinant proteins in mammalian cells (Wurm, 2004). In my experiments, small 
interference RNA (siRNA) procedures were used. In the last few years, siRNAs have been used 
in a number of different experimental settings to silence gene expression. In some, chemically 
synthesized or in vitro transcribed siRNAs have been transfected into cells, injected into mice, 
or introduced into plants (e.g. by a particle gun). In others, siRNAs have been expressed 
endogenously from siRNA expression vectors or PCR products in cells or in transgenic 
animals. RNA interference (RNAi) is a phenomenon in which the introduction of dsRNA into a 
diverse range of organisms and cell types causes degradation of the complementary mRNA 
(Fig. 19, step 1). In the cell, long dsRNAs are cleaved into short 21-25 nucleotide small 
interfering RNAs, or siRNAs, by a ribonuclease known as Dicer (step 2). The siRNAs  
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subsequently assemble with protein components into an RNA-induced silencing complex 
(RISC), unwinding in the process (step 3). Activated RISC then binds to complementary 
transcript by base pairing interactions between the siRNA antisense strand and the mRNA. 
The bound mRNA is cleaved (step 4) and sequence specific degradation of mRNA (step 5) 
results in gene silencing (McManus, 2002; Dillin A, 2003; Tuschl, 2002).  
 
Fig. 19 RNAi Mechanism [26]  
 
Protein quantification 
A rapid and accurate method for the estimation of protein concentration is essential for WB 
analysis. In my experiments it was used an assay described by Bradford (Bradford, 1976): it is 
a protein determination method that involves the binding of Coomassie Brilliant Blue G-250 
dye to proteins (Bradford, 1976). The dye exists in three forms: cationic (red), neutral (green), 
and anionic (blue). Under acidic conditions, the dye is predominantly in the red cationic form 
(Amax=470 nm). However, when the dye binds to protein, it is converted to a stable  
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unprotonate blue form (Amax=595 nm) (Reisner et al. 1975, Fazekes de St. Groth et al. 1963, 
Sedmack and Grossberg 1977). It is this blue protein-dye form that is detected at 595 nm in 
the assay using a spectrophotometer or microplate reader. In any protein assay, the ideal 
protein to use as a standard is a purified preparation of the protein being assayed. In the 
absence of such an absolute reference protein, another protein must be selected as a relative 
standard. The best relative standard to use is one that gives a color yield similar to that of the 
protein being assayed. Selecting such a protein standard is generally done empirically. 
Alternatively, if only relative protein values are desired, any purified protein may be selected 
as a standard. The two most common protein standards used for protein assays are bovine 
serum albumin (BSA) and gamma-globulin. In my experiments, to quantify the protein 
concentration in each sample, a standard curve it was used, considering the lowest point 
(white) and the highest point of the curve (15 mg/ml of BSA) with other intermediate 
concentrations: 10, 5, 2, 1 mg/ml. 
 
 
Western Blot (WB) 
WB is an important technique used in cell and molecular biology. WB is often used in research 
to separate and identify proteins. In this technique a mixture of proteins is separated based 
on molecular weight through gel electrophoresis.  Polyacrylamide gel is generally used for the 
electrophoretic separation of proteins, and Sodium Dodecyl Sulfate (SDS) is generally used as 
a buffer (as well as in the gel) in order to give all proteins present a uniform negative charge, 
since proteins can be positively, negatively, or neutrally charged. This type of electrophoresis 
is known as SDS-polyacrylamide gel electrophoresis (PAGE). Prior to electrophoresis, protein 
samples are quantified (as described) and are boiled to denature the proteins present. This  
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ensures that proteins are separated based on size and prevents proteases (enzymes that 
break down proteins) from degrading samples. Following electrophoretic separation, the 
proteins are transferred to a membrane (typically nitrocellulose or PVDF, where they are 
blocked with milk (or other blocking agents). The membrane is then incubated with labels 
antibodies specific to the protein of interest. The unbound antibody is washed off leaving only 
the bound antibody to the protein of interest. As the antibodies only bind to the protein of 
interest, only one band should be visible. The thickness of the band corresponds to the 
amount of protein present; thus doing a standard can indicate the amount of protein present 
(Mahmood et al., 2012).  
In my experiments, the proteins were detected by chemiluminescent methods that depend 
on incubation of the western blot with a substrate that will luminesce when exposed to the 
reporter on the secondary antibody. The light is then detected by charge-coupled device 
(CCD) camera, which capture a digital image of the western blot or photographic film. The use 
of film for western blot detection is slowly disappearing because of non-linearity of the image 
(non accurate quantification). The image is analyzed by densitometry, which evaluates the 
relative amount of protein staining and quantifies the results in terms of OD. Newer software 
allows further data analysis such as molecular weight analysis if appropriate standards are 
used. 
 
Immunoprecipitation (IP) and co-immunoprecipitation (Co-IP) 
 
Proteins generally act by binding to other molecules, including proteins. When proteins bind 
to other proteins, it is possible to speak of protein-protein interactions. It has become 
apparent that protein-protein interactions are critically important to many processes that  
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take place in the cell, including signal transduction, regulation of gene expression, vesicular 
transport, nuclear import and export, and cell migration (Pawson and Nash, 2003). This has 
led to the recognition of protein-protein interactions as targets for drug development and to 
an increased interest in the identification of novel protein-protein interactions (Fry and 
Vassilev, 2005; Fry, 2006). Co-IP is a technique that is used to confirm novel protein-protein 
interactions in the context of a living cell or organism. In addition, Co-IP is also used to study 
the dynamics of protein-protein interactions in response to intra- or extracellular stimuli. In a 
Co-IP experiment, a protein of interest is isolated by IP. IP is one of the most widely used 
methods for antigen detection and purification. The principle of an IP is very straightforward 
(Fig. 20): an antibody (monoclonal or polyclonal) against a specific target protein forms an 
immune complex with that target in a sample, such as a cell lysate. The immune complex is 
then captured, or precipitated, on a beaded support to which an antibody-binding protein is 
immobilized (such as Protein A or G), and any proteins not precipitated on the beads are 
washed away. Finally, the antigen (and antibody, if it is not covalently attached to the beads 
and/or when using denaturing buffers) is eluted from the support and analyzed by SDS-PAGE, 
often followed by WB detection to verify the identity of the antigen. Co-IP is an extension of 
IP that is based on the potential of IP reactions to capture and purify the primary target (i.e., 
the antigen) as well as other macromolecules that are bound to the target by native 
interactions in the sample solution.  
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Fig. 20 Schematic summary of a standard immunoprecipitation assay [27]  
 
Subsequently, the presence of binding partners can be assessed by immunoblotting. If the 
proteins are bound, it is possible to visualize on the same membrane them. Anyway, if the 
proteins are not bound, It is possible to visualize the immunoprecipitated protein.  
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RESULTS of “Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the 
induction of IL-18 in human keratinocytes”. 
 
The first objective of my thesis was to investigate the molecular mechanism underlying 
contact allergen-induced IL-18 production in human KCs (Papale et al., 2017). To identify 
genes selectively upregulated by contact allergens and correlated with the activation of the 
inflammasome a commercially available inflammasome RT2 Profiler PCR array was used. NCTC 
2544 cells were treated for 6 h with PPD (30 μg/ml) or with DMSO as vehicle control. In Table 
6, the more activated genes identified in this preliminary screen are reported. 
 
Table 6. Genes overexpressed by PPD in NCTC 2544 cells following 6 h of treatment [28] 
 
To confirm these results, cells were treated for 3, 6, 24 h with PPD (30 μg/ml) or DMSO as 
vehicle control. Even with different kinetics, the expression of CARD18, NLRP12, NLRX1 and 
CCL5 could be confirmed by real-time PCR (Fig. 21), while the upregulation of CCL7 was not. 
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Fig. 21 Induction of the selected genes by real-time PCR [28]. NCTC 2544 cells were treated for 3, 6, 24 h with 
PPD 30 μg/ml, or DMSO as vehicle control. To confirm the expression of the identified genes, real-time PCR was 
used, as described in “Materials and methods” section. Each value represents the mean ± SEM of n= 3 
independent experiments. Statistical analysis was performed with analysis of variance followed by Dunnett’s 
test, with **p < 0.01 and #p < 0.05 versus vehicle-treated cells at the different time points.  
 
 
Among these four genes, NLRP12 was chosen by a bibliographic search on ACD and its role in 
contact allergen-induced KCs activation was investigated. Its expression and specific role in 
KCs is currently unknown, which represented an additional challenge.  NLRP12/Monarch1 is 
an intracellular protein consisting of an N-terminal PYD, a central NACHT (NOD domain) and 
a C-terminal leucine-rich repeat (LRR) region (Tuncer et al., 2014). The full-length human 
NLRP12 cDNA encodes for 1062-aa protein with an estimated molecular weight of 
approximately 120 kDa (Ye et al., 2008). Human NLRP12 is expressed predominantly in cells 
of myeloid lineage, including neutrophils, eosinophils, monocytes, macrophages and 
immature dendritic cells, and its expression is downregulated in response to pathogens, 
pathogens products and inflammatory cytokines, indicative of an inhibitory role in innate 
immune activation (Wu et al., 2013; Shami et al., 2001; Wang et al., 2002; Lich et al., 2007). 
Moreover, Lord et al. (2009) found that the promoter of NLRP12 contains a Blimp-1/PRDM1 
binding site. It has been shown that Blimp-1 reduces NLRP12 activity and expression in 
myeloid cells during cell differentiation (Martins et al., 2006; Chang et al., 2000). 
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To investigate the effects of contact allergens on NLRP12 and Blimp-1 expression in KCs, dose-
response and time-course experiments were performed. The expression of NLRP12 and 
Blimp-1 was investigated both at the mRNA and protein level. Cells were treated with the 
extreme sensitizer DNCB (LLNA EC3= 0.05%) and the strong allergen PPD (LLNA EC3= 0.11%) 
at concentrations selected from previously published data (Corsini et al., 2009). As NLRP12 
and Blimp-1 are reported to be inversely related (Lord et al. 2009), data are presented as ratio 
Blimp-1/NLRP12. An increased Blimp-1/NLRP12 ratio should be indicative of increased 
inflammasome activation. As shown in Fig. 22, both allergens modulated NLRP12 and Blimp-
1 gene expression with a different kinetic. In the first series of experiments, cells were treated 
with increasing concentration of DNCB (1-2 μg/ml) and PPD (7.5-30 μg/ml) for 3, 6 and 24 h. 
No changes were observed with DNCB (Figure 22 a), while PPD showed statistically significant 
changes in Blimp-1/NLRP12 ratio at 6 h (Fig. 22 b). This prompted us to investigate the effect 
of DNCB at earlier time points. Cells were, then, treated for 30 min, 1 and 2 h. As shown in 
the inset of Fig. 22 a, DNCB induced a very early activation of Blimp-1, suggesting that extreme 
allergens may more rapidly activate the inflammasome.  
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Fig. 22 Effects of contact allergens on NLRP12 and Blimp-1 gene expression [28]. NCTC 2544 cells were treated 
for different times with DNCB 1-2 μg/ml (a) and PPD 7.5-30 μg/ml (b) or DMSO as vehicle control. After 
treatments, NLRP12 and Blimp-1 mRNA expression was evaluated by real-time PCR, as described in “Materials 
and methods” section. Results are expressed as Blimp-1/NLRP12 ratio. Each value represents the mean ± SEM 
of n= 3 independent experiments. Statistical analysis was performed with analysis of variance followed by 
Dunnett’s test, with *p<0.05, **p<0.01 versus vehicle treated cells at the different time points. 
 
 
In a similar way, as shown in Fig. 23, both allergens modulated NLRP12 and Blimp-1 protein 
expression. In particular, the extreme allergen DNCB modulated the expression already at 30 
min (Fig. 23 a), while the strong allergen PPD modulated protein expression after 24 h of 
treatment (Fig. 23 b). In both cases, contact allergens induced an increase of Blimp-1 protein 
expression and a decrease of NLRP12 protein expression, where the extreme allergen more 
rapidly modulated their expression (Fig. 23 a). As a consequence of an increase of Blimp-1 
protein expression and a decrease of NLRP12 protein expression, a different kinetic of IL-18 
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production was observed, with DNCB inducing a more rapid (3 h) production of IL-18 (Fig. 23 
c) compared to PPD (Fig. 23 d). 
 
 
Fig. 23 Effects of contact allergens on NLRP12 and Blimp-1 protein expression [28]. NCTC 2544 cells were 
treated for different times with DNCB 1-2 μg/ml (a) and PPD 7.5-30 μg/ml (b) or DMSO as vehicle control. After 
treatment, NLRP12 and Blimp-1 protein expression was assessed by Western blot analysis. Representative 
Western blots are reported at 30 min and 6 h for DNCB (a) and 24 h for PPD (b). At 3, 6, 12 and 24 h IL-18 
production was assessed by ELISA (c, d). Results are expressed as mean±SEM of n= 3 independent experiments. 
Statistical analysis was performed with analysis of variance followed by Dunnett’s test, with *p < 0.05, **p < 
0.01 and #p < 0.05 versus vehicle-treated cells at the different time points. 
 
NLRP12 is one of the most elusive members of the NLR family. In monocytes/macrophages, 
its expression is associated with the shutdown of the inflammatory response (Arthur et al., 
2010). To investigate its role in IL-18 production, the effects of inducing RNA interference on 
NLRP12 and Blimp-1 were assessed. NCTC 2544 cells were transfected with NLRP12 and 
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Blimp-1 siRNA for 48 h. After transfection, cells were treated for 24 h with DNCB 2 μg/ml or 
PPD 15 μg/ml and intracellular IL-18 production assessed by ELISA. As shown in Fig. 24, 
NLRP12 silencing, despite its reduced expression both at mRNA and protein level (Fig. 24 a, 
b), did not result in increased allergen-induced IL-18 production (Fig. 24 e, f), while Blimp-1 
silencing was associated with a significant induction of NLRP12 mRNA and protein expression 
(Fig. 24 c, d), which resulted in a significant reduction in contact allergen-induced IL-18 (Fig. 
24 e, f). These data are suggestive of an inhibitory role of NLRP12 in inflammasome activation, 
consistent with data reported in immune cells (Lord et al., 2009).  
 
 
Fig. 24 Effects of NLRP12 and Blimp-1 silencing on contact allergen induced IL-18 production [28]. NCTC 2544 
cells were transfected with NLRP12 and Blimp-1 siRNA for 48 h. After silencing, gene expression was assessed 
by real-time PCR (a, c), while protein expression was assessed by Western blot analysis (b, d) with representative 
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Western blots shown. After silencing, cells were treated with DNCB (2 μg/ml) or PPD (15 μg/ml) for 24 h and 
then IL-18 production was assessed by ELISA (e, f). Results (a, b, c, d) are expressed as mean ± SEM of n= 3 
independent experiments. Statistical analysis was performed with analysis of variance followed by Dunnett’s 
test, with *p < 0.05, **p < 0.01, #p < 0.05 and ##p < 0.01 versus vehicle (transfection reagent)-treated cells. 
Results (e, f) are expressed as mean ± SEM of n= 3 independent experiments. Statistical analysis was performed 
with analysis of variance followed by Dunnett’s test, with ##p < 0.01 versus DNCB or PPD alone. 
 
To strengthen these results, an experiment was set up upregulating Blimp-1 expression by 
treating cells with DNCB 1 μg/ml for 6 h (Fig. 25). Cells were then extensively washed with 
culture media to remove DNCB and then exposed to PPD 30 μg/ml or DMSO as vehicle control 
for 18 h. 
As shown in Fig. 25, a statistically significant increase was observed in cells pulse DNCB 
compared to cells exposed to DMSO 6 h + PPD 18 h, further supporting our hypothesis.  
 
 
 
Fig. 25 Effects of Blimp-1 induction on allergen-induced IL-18 production [28]. NCTC 2544 cells were treated 
with DNCB 1 μg/ml or DMSO as vehicle control for 6 h and then with DNCB 1 μg/ml or PPD 30 μg/ml for 18 h, 
and IL-18 production was assessed by ELISA. Results are expressed as mean ± SEM of n= 3 independent 
experiments. Statistical analysis was performed with analysis of variance followed by Dunnett’s test, with **p < 
0.01 versus vehicletreated cells and *p < 0.05 versus vehicle + PPD 30 μg/ml-treated cells. 
 
Similarly, to confirm the results obtained in the NCTC 2544 cell line, a more realistic model 
was used. Commercially available RhE was used. RhE was transfected with NLRP12 and Blimp-
1 siRNA for 48 h. After transfection, RhE was treated for 24 h with DNCB 1.5 mg/ ml or with 
AOO as vehicle control. The amount of IL-18 present in culture supernatants was quantified 
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by ELISA. As shown in Fig. 26, Blimp-1 silencing was associated with the induction of NLRP12 
(Fig. 26 b), as observed in the NCTC 2544 cells. Under this experimental condition, a 
statistically significant reduction in DNCB-induced IL-18 release was observed in RhE in which 
Blimp-1 was silenced (Fig. 26 c), confirming results obtained in the KCs cell line. Also in this 
case, NLRP12 silencing failed to upregulate DNCB-induced IL-18 production, suggesting that 
the remaing NLRP12 was sufficient to balance allergen-induced inflammasome activation and 
IL-18 production. On the contrary its upregulation resulted in a reduction of contact allergen-
induced IL-18 production. 
 
 
Fig. 26 Effect of NLRP12 and Blimp-1 silencing in reconstructed human epidermis [28]. RHE was transfected 
with NLRP12 and Blimp-1 siRNA for 48 h. After silencing, gene expression was assessed by real-time PCR (a, b). 
After silencing, RHE was exposed to DNCB (1.5 mg/ml) or AOO as vehicle control for 24 h, and IL-18 release was 
assessed by ELISA (c). Results are expressed as mean ± SEM of n= 3 independent experiments. Statistical analysis 
was performed with analysis of variance followed by Dunnett’s test, with # p<0.05 versus vehicle (transfection 
reagent)-treated cells (a, b). Results are expressed as mean ± SEM of n= 3 independent experiments. Statistical 
analysis was performed with analysis of variance followed by Dunnett’s test, with ##p<0.01 versus DNCB alone 
(c). 
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DISCUSSION of “Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in 
the induction of IL-18 in human keratinocytes”. 
 
The first objective of my thesis was to better understand the molecular mechanism involved 
in contact allergen-induced inflammasome activation and IL-18 production. Using the 
inflammasome RT2 Profiler PCR array, among the genes selectively upregulated by PPD, 
NLRP12 was identified.  We could then demonstrate that DNCB and PPD differently affected 
Blimp-1/NLRP12 expression. Interestingly, the extreme allergen DNCB more rapidly 
downregulated NLRP12 expression and more rapidly induced IL-18 production. As 
demonstrated in monocytes/macrophages (Williams et al., 2005) also in KCs, NLRP12 and 
Blimp-1 expression is inversely correlated. IL-18 is a cytokine that plays a key proximal role in 
the induction of allergic contact sensitization and favors Th-1-type immune response by 
enhancing the secretion of proinflammatory mediators such TNF-α and interferon-
γ (Okamura et al., 1995; Cumberbatch et al., 2001; Antonopoulus et al., 2008). Human KCs 
constitutively express IL-18 mRNA and protein, and it has been shown its induction following 
exposure to contact sensitizers (Corsini et al., 2009; Galbiati and Corsini, 2012; Naik et al., 
1999). 
NLRP12, in contrast to other NLR proteins that promote inflammation, acts as an attenuator 
of inflammatory responses (Ye et al., 2008), and it has been characterized in 
monocytes/macrophages as a negative regulator of both canonical and non-canonical NF-κB 
signaling (Lich et al., 2007). NLRP12 was also found to attenuate the development of contact 
hypersensitivity (Arthur et al., 2010). More recently, mutations that result in a truncated form 
of NLRP12 were linked to hereditary periodic fevers that manifest with recurrent fevers, joint 
pain and skin urticaria (Jéru et al., 2008). 
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Lord et al. (2009) found that reducing NLRP12 expression with small interference RNA in 
myeloid/monocyte cells, an increase in NF-κB activation and cytokine expression in response 
to TLR2/TLR4 agonists (TNF-α was observed, suggesting that NLRP12 is a negative regulator 
of inflammation). The NLRP12 promoter contains a Blimp-1/PRDM1 binding site. It has been 
shown that Blimp-1 reduces NLRP12 activity and expression (Williams et al., 2005). The 
expression of NLRP12 and Blimp-1 appears to be inversely correlated. It has been proposed 
that the transcriptional silencing of NLRP12 is essential for the development of a proper 
immune response (Struwe and Warren, 2010). NLRP12 gene silencing is mediated by Blimp-1 
during both innate immune activation and cellular differentiation (Lord et al., 2009). We 
speculate that the ability of different allergens to induce IL-18 may be linked to their ability 
to modulate NLRP12 and Blimp-1 gene and protein expression differently, depending on their 
potency. Indeed different kinetics were observed, with the extreme allergen DNCB 
modulating Blimp-1/NLRP12 gene and protein expression more rapidly, compared to the 
strong allergen PPD. 
SiRNA is widely used to silence the expression of specific genes to assess the individual 
contribution of these genes to an assortment of cellular phenotypes. In order to understand 
the role of NLRP12 and Blimp-1 in allergen induced IL-18 production, silencing experiments 
were performed. Silencing Blimp-1, the gene and protein of NLRP12 was significantly 
increased, supporting the role of Blimp-1 as repressor of NLRP12 expression (Williams et al., 
2005). The following scenario can be imagined (Fig. 27): in non - activated situation NLRP12 
acts as a negative regulator of inflammation, preventing the inflammasome activation and 
consequently IL-18 production (Fig. 27 a), on the contrary following exposure to contact 
allergens, Blimp-1 expression significantly increase to downregulate NLRP12 expression, 
which in turn facilities the activation of the inflammasome and IL-18 maturation (Fig. 27 b). 
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The inhibitory role of NLRP12 in IL-18 production was evident after Blimp-1 silencing, which 
resulted in NLRP12 overexpression and in an almost complete abrogation of contact allergen-
induced IL-18 production. Equally, inducing Blimp-1 by DNCB, a statistical increase in PPD-
induced IL-18 was observed, supporting the role of NLRP12 as negative regulator of 
inflammation. Surprisingly, NLRP12 downregulating did not result in increased contact 
allergen induced IL-18 production, suggesting that in our experimental conditions, the degree 
of reduction was not sufficient to significantly affect inflammasome activation and IL-18 
production induced the strong allergens used.  
 
 
 
Fig. 27 NLRP12 and Blimp-1 role in inflammasome activation [28]. NLRP12 is supposed to act as a negative 
regulator of inflammation before immune stimulation (a), but during infection its expression is reduced to allow 
for a full inflammatory response. In this contest, Blimp-1 plays a pivotal role (b): It is a repressor of NLRP12. 
NLRP12 inhibition leads to inflammasome activation and the activated caspase-1 drives the proteolytic cleavage 
of pro-IL-18 in IL-18. 
 
 
In conclusion, we demonstrated the role of NLRP12 and Blimp-1 in contact allergen-induced 
IL-18 production in human KCs.  
  105 
RESULTS of “NLRP12 protein and the NLRP3 inflammasome complex in the induction of IL-
18 in human keratinocytes: further developments” 
 
I next investigated contact allergen-induced caspase-1 activation and by immunoprecipitation 
the link of NLRP12 with the inflammasome NLRP3 (manuscript in preparation). 
NLRP3 inflammasome consists of three different protein: NLRP3, ASC and Caspase-1, I wanted 
to investigate if contact allergens could modulate these three proteins and where NLRP12 
protein could bind within the inflammasome by immunoprecipitation experiments. 
To investigate the effects of contact allergens on NLRP3 protein expression, dose-response 
and time-course experiments were performed. NCTC 2544 cells were treated for different 
times with increasing concentration of PPD and DNCB. 
 As shown in Fig. 28, both allergens upregulated NLRP3 with a similar kinetic but with DNCB 
inducing an higher up-regulation at 3 h compared to PPD. In the first series of experiments, 
cells were treated with increasing concentration of PPD (7.5-30 μg/ml) and DNCB (1-2 μg/ml) 
for 3, 6 and 24 h. PPD showed statistically significant increase at all time investigated, with 
higher induction observed at 24 h (Fig. 28 a), while a more rapid NLRP3 protein production 
was observed with DNCB (Fig. 28 c), suggesting that extreme allergen may more rapidly 
activate the inflammasome. In Fig. 28 b, the results of co-immunoprecipitation experiment 
with PPD 30 μg/ml at 24h of treatment were shown. NLRP12 was immunoprecipitated and as 
expected a reduction in NLRP12 in PPD treated cells was observed. Nevertheless, NLRP3 co-
precipitated with NLRP12 in both control and treated cells.  
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Fig. 28 Effects of contact allergens on NLRP3 protein expression and analysis of interaction between NLRP12 
and NLRP3 by Co-IP experiments [29]. 
NCTC 2544 cells were treated for different times with PPD 7.5, 15 and 30 μg/ml (a) and DNCB 1, 1.5 and 2 μg/ml 
(c) or DMSO as vehicle control. After treatment, NLRP3 expression was assessed by WB analysis. Representative 
blots are reported at the bottom of each graph. Results are expressed as mean ± SEM of n= 3 independent 
experiments. Statistical analysis was performed by Dunnett’s test, with **p<0,01 and *p<0,05 versus vehicle-
treated cells at different point.  
NCTC 2544 cells were treated for 24 h with 30 μg/ml or DMSO as vehicle control and immunoprecipitated by 
anti-NLRP12 specific antibody, NLRP3 protein was then visualized by WB in NLRP12 immunoprecipitated 
samples (b). 
 
 
In a similar way, the effect of contact allergens on ASC protein expression was investigated in 
dose-response and time-course experiments. NCTC 2544 cells were treated for different 
times with increasing concentrations of the strong allergen PPD and the extreme sensitizer 
DNCB. As shown in Fig. 29, both allergens also induced ASC protein with a different kinetic. In 
the first series of experiments, cells were treated with increasing concentration of PPD (7.5-
30 μg/ml) and DNCB (1-2 μg/ml) for 3, 6 and 24 h. PPD showed an up-regulation that reached 
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statistically significance at 6 and 24h, while a more rapid ASC protein production already at 3 
h (p<0.05) were observed with DNCB, (Fig. 29 c), suggesting that extreme allergen may more 
rapidly activate the inflammasome, confirming previous results (Papale at al., 2017). In Fig. 
29 b, the results of co-immunoprecipitation experiment with PPD 30 μg/ml at 24 h of 
treatment are shown. NLRP12 was immunoprecipitated and as already shown in Fig. 28 c  in 
the control group there is more NLRP12, however, while NLRP12 clearly co-
immunoprecipitated in allergen-treated cells, ASC seems to associate to NLRP12 only in 
control cells. This suggest that following allergen exposure NLRP12 is displaced from ASC, 
leaving it free to interact with pro-caspase-1 facilitating its activation. 
 
 
Fig. 29 Effects of contact allergens on ASC protein expression and analysis of interaction between NLRP12 and 
ASC by coimmunoprecipitation [29].  
NCTC 2544 cells were treated for different times with PPD 7.5, 15 and 30 μg/ml (a) and DNCB 1, 1.5 and 2 μg/ml 
(c) or DMSO as vehicle control. After treatment, ASC expression was assessed by WB analysis. Representative 
blots are reported at the bottom of each graph. Results are expressed as mean ± SEM of n= 3 independent 
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experiments. Statistical analysis was performed by Dunnett’s test, with **p<0,01 and *p<0,05 versus vehicle-
treated cells at different point.  
NCTC 2544 cells were treated for 24 h with 30 μg/ml or DMSO as vehicle control and immunoprecipitated by 
anti-NLRP12 specific antibody, ASC protein was then visualized by WB in NLRP12 immunoprecipitated samples 
(b). 
 
Finally the effect of contact allergens on caspase-1 activation was investigated in dose-
response and time-course experiments. NCTC 2544 cells were treated for different times with 
the strong allergen PPD and the extreme sensitizer DNCB. 
As shown in Fig. 30, both allergens induced Caspase-1 activation with a different kinetic, 
consistent with the previously published IL-18 production (Papale et al., 2017). In the first 
series of experiments, cells were treated with increasing concentration of PPD (7.5-30 μg/ml) 
and DNCB (1-2 μg/ml) for 3, 6 and 24 h. The results are expressed as ratio between caspase-
1/pro-caspase-1, to appreciate the activation of caspase-1. PPD showed statistically 
significant activation at 24 h (Fig. 30 a), while a more rapid caspase-1 activation already at 3 
h (p< 0,01) was observed with DNCB, (Fig. 30 c), further supporting the idea that extreme 
allergens more rapidly activate the inflammasome and IL-18 maturation. In Fig. 30 b, the 
results of co-immunoprecipitation experiment with PPD 30 μg/ml at 24 h of treatment were 
shown.  
I then wanted to investigate if caspase-1 associated with NLRP12. NLRP12 was 
immunoprecipitated and clearly caspase-1 protein was bound to NLRP12 protein in both 
control and allergen treated cells. 
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Fig. 30 Effects of contact allergens on caspase-1 activation and analysis of interaction between NLRP12 and 
caspase-1 by co-immunoprecipitation [29].  
NCTC 2544 cells were treated for different times with PPD 7.5, 15 and 30 μg/ml (a) and DNCB 1, 1.5 and 2 μg/ml 
(c) or DMSO as vehicle control. After treatment, caspase-1 activation was assessed by WB analysis. 
Representative blots are reported at the bottom of each graph. The results are expressed as a ratio between 
activated caspase-1/pro-caspase-1 and as mean ± SEM of n=3 independent experiments. Statistical analysis was 
performed by Dunnett’s test, with **p<0,01 versus vehicle-treated cells at different point.  
NCTC 2544 cells were treated for 24 h with 30 μg/ml or DMSO as vehicle control and immunoprecipitated by 
anti-NLRP12 specific antibody, caspase-1 protein was then visualized by WB in NLRP12 immunoprecipitated 
samples (b). 
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DISCUSSION of “NLRP12 protein and the NLRP3 inflammasome complex in the induction of 
IL-18 in human keratinocytes: further developments”. 
 
The second part of my thesis aimed to understand the modulation of NLRP3 inflammasome 
by contact allergen of different potency in human KCs. NCTC 2544 were treated with the 
strong allergen PPD and the extreme allergen DNCB. In addition, the localization of NLRP12 
was clarified in NLRP3 inflammasome complex by co-immunoprecipitation experiments. 
NLRP3 is a multiproteic complex composed by three proteins: a cytosolic receptor, NLRP3, an 
adopter protein, ASC and the effector protein, caspase-1 (Schroder and Tschopp, 2010). The 
working hypothesis was that allergens of different potency may differently activate the NLRP3 
inflammasome dipending on their potency. Indeed different kinetics were observed, with the 
extreme allergen DNCB induces more rapid activation of all of them, compared to the strong 
allergen PPD.  
I then wanted to link NLR12 with NLRP3 inflammasome by investigating its localization by 
immunoprecipitation. Co-immunoprecipitation is a technique that is used to confirm protein-
protein interactions. In order to understand the link of NLRP12 and the NLRP3 inflammasome 
proteins, co-immunoprecipitation experiments were performed by immunoprecipitating 
NLRP12 and assessing the co-precipitation of NLRP3, ASC and pro-caspase-1 by Western blot 
analysis. While in control cells, NLRP3, ASC and pro-caspase-1 co-immunoprecipitated with 
NLRP12, in allergen treated cells a decrease in ASC associated NLRP12 was observed, which 
could shift ASC to a better bond with NLRP3 and pro-caspase-1 so as to favor its activation 
and release.  
Similar experiments will be conducted with DNCB. 
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RESULTS of “Development of an in vitro method to estimate the sensitization induction 
level of contact allergens”.  
 
The other objective of my thesis was to optimize an in vitro system for the estimation of the 
No Estimation Sensitization Induction Level (NESIL) necessary for risk assessment and full 
replacement of experimental animals for the characterization of skin sensitizers. The RhE IL-
18 assay previously developed in our laboratory in collaboration with S.Gibbs at the VU 
Medical Centre in Amsterdam was used as experimental model. 
Additional 14 chemicals using commercially available EpiDerm™ model (Galbiati et al., 2017). 
Chemicals were selected from the ICCVAM database. Allergens of different potency (1 
extreme, 2 strong, 3 moderate and 4 weak) were investigated together with chemicals 
misclassified at the LLNA, namely benzyl salicylate and benzyl cinnamate for which no 
sensitization was observed in human predictive studies, and benzyl alcohol for which positive 
responses were reported in humans. In Table 7, the LLNA EC3 and the human NOEL or LOEL 
values are reported.  
 
 
Table 7. Chemical tested and in vivo LLNA potency classification [30]  
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Experiments were run accordingly with the SOP developed for the EE IL-18 assay (Gibbs et al., 
2013; Teunis et al., 2013, 2014), which foresees two independent runs for each chemical to 
be tested. RhE was exposed to the selected chemicals for 24 h as described in materials and 
methods section. Cell viability was assessed by the MTT assay and IL-18 release by ELISA. Of 
the selected chemicals, only benzoquinone had to be excluded due to its interference with 
both MTT assay and the ELISA. The results obtained in two independent experiments are 
shown in Fig. 31 for each compound five increasing concentrations were tested. Graphics on 
the left show cell viability, while IL-18 release is shown on the right (stimulation index). Dotted 
lines were set at 50% viability and IL-18 SI-2, cut off for positivity. 
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Fig. 31 Dose-response effects of the selected compounds on cell viability and IL-18 release [30]. Data obtained 
from two independent experiments are represented (1° and 2° exp). RhE was exposed to increasing 
concentrations of the selected chemicals for 24 h. Viability was assessed by MTT while IL-18 by ELISA. Viability 
(A, C, E, G, I, M, O) is expressed as % vs vehicle treated RhE (100%), and IL-18 as stimulation index (SI) compared 
to vehicle treated RhE (B, D, F, H, L, N, P). The dotted lines are set at 50% viability and IL-18 SI-2.  
 
 
The contact allergens chlorpromazine, chloramine T, diethyl maleate, dihydroeugenol, 2,4- 
dichloronitrobenzene, imidazolidinyl urea and limonene were able to a different extend to 
induce a IL-18 SI ≥ 2.0, while the non-sensitizers isopropanol and 4-aminobenzoic acid (Fig. 
32) failed to induce IL-18 release.  
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Fig. 32 Dose-response effects of the selected non-sensitizers on cell viability and IL-18 release [30]. Data 
obtained from two independent experiments are represented (1° and 2° exp). RhE was exposed to increasing 
concentrations of the selected chemicals for 24 h. Viability was assessed by MTT while IL-18 by ELISA. Viability 
(A, C, E) is expressed as % vs vehicle treated RhE (100%), and IL-18 as stimulation index (SI) compared to vehicle 
treated RhE (B, D, F). The dotted lines are set at 50% viability and IL-18 SI-2.  
 
Comparing the two experiments, cytotoxicity data are less variable compared to the release 
of IL-18, which may reflect a different degree of KCs activation between different RhE batches. 
This greater variability is also seen in the data obtained with the positive control DNCB 2 
mg/ml: IL18 SI 15.4 ± 4.9 (min 8.0, max 24.4), viability 11.6 ± 3.6% (min 6.9, max 16.2), data 
is mean SD, n= 11 independent experiments. Despite this, the positive/negative classification 
is not affected as for the prediction model the fold increase in intracellular IL-18 is ≥ 2.0 in at 
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least one of the concentrations tested in two independent experiments the chemical is 
classified chemical as contact sensitizer. The correlation between cytotoxicity and the 
strength of IL-18 release is not always straightforward. For some allergens, the decrease in 
cell viability is associated with the increase in IL-18 release. In other cases, increased IL-18 
release can be observed at not cytotoxic concentrations, as in the case of limonene where a 
dose related release of IL-18 was observed in the absence of cytotoxicity. 
An unexpected dose-related IL-18 release was observed with dimethyl isophthalate (Fig. 32 
D). While no EC50 values were obtained, IL-18 SI-2 could be calculated: 69.2 mg/ml in the 1 
exp and 26.1 mg/ml in the 2 exp. This compound is classified as a not sensitizer in the LLNA. 
In spite of phthalates being widely used additives in plastics, there are few reports of skin 
problems caused by them (Johansen et al., 2011), and two cases of contact allergy to dimethyl 
phthalate has been reported (Capon et al., 1996), which may support the positive result 
observed. In Fig. 33 data obtained with the misclassified compound are reported. Benzyl 
cinnamate (Fig.  33 A, B) and benzyl salicylate (Fig. 33 C, D) are classified in the LLNA as contact 
sensitizers (moderate and weak, respectively), and in the RhE IL-18 assay as non-sensitizers 
since they failed to induce IL-18 release. Benzyl salicylate is classified as a not relevant human 
allergen (Lapczynski et al., 2007; Schnuch et al., 2007; Urbisch et al., 2015) and there are no 
human data for benzyl cinnamate that support its classification as contact sensitizer (Bhatia 
et al., 2007; Ohkawara et al., 2010; Api et al., 2008). These two compounds are considered as 
false positives in the LLNA, both of which were properly classified by the RhE IL-18 assay. 
Otherwise, benzyl alcohol (Fig. 33 E, F), classified as a non-sensitizer based on the LLNA data, 
scored as a contact sensitizer with IL-18 RhE assay as it was able to reach an IL-18 stimulation 
index 2.0. Literature research showed that benzyl alcohol is sensitizer in humans (Api et al., 
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2007; Belsito et al., 2012; Scognamiglio et al., 2012). Thus, these three chemicals were 
correctly classified in the IL-18 RhE assay.  
 
 
Fig. 33. Effects on cell viability and IL-18 release of chemicals misclassified in the LLNA [30]. RhE was treated 
for 24 h with increasing concentrations benzyl salicylate (A, B), benzyl cinnamate (C, D), and benzyl alcohol (E, 
F). Viability was assessed by MTT while IL-18 by ELISA. Viability (A, C, E) is expressed as % vs vehicle treated RhE 
(100%), and IL-18 as stimulation index (SI) compared to vehicle treated RhE (B, D, F). The dotted lines are set at 
50% viability and IL-18 SI-2.  
 
As it is emerging in many other in vitro studies, data obtained using human cells seem to 
correlate better with in vivo human data. Nevertheless, additional weak allergens should be 
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tested to define whether the RhE IL-18 assay can correctly identify weak allergens and false 
negative compounds at the LLNA.  
In vitro EC50 and IL-18 SI2 showed a good correlation with in vivo LLNA EC3 and human DSA05 
(Gibbs et al., 2013). The next step was to investigate the possibility to use a simple approach 
to estimate the in vivo induction sensitization level, based on these two values. Curves were 
created, using reference skin sensitizers of different potency, namely DNCB, isoeugenol, 
cinnamal and benzocaine in vitro and in vivo data. In Table 8, the in vivo and in vitro values 
for the reference contact allergens are reported. 
 
Table 8. Reference contact sensitizers used to create the regression curves for the estimation of the in vivo 
EC3 and human NOEL [30]. In vivo values were obtained from ICCVAM database (NIH Publication No. 11-7709), 
Research Institute for Fragrance Materials (RIFM) database, Griem et al. (2003), Api et al. (2008), Natsch et al. 
(2013), Basketter et al. (2014), Urbisch et al. (2015). In vitro EC50 and IL-18 SI2 values are the arithmetic means 
obtained in two independent experiments, and were calculated from RhE exposed to the selected compounds 
as described in matherials and methods. 
 
 Linear regression curves were created by plotting in vivo LLNA EC3 or human NOEL values 
against in vitro EC50 or IL-18 SI2 arithmetic mean values (Fig. 34). A R2 > 0.90 with a p < 0.05 
was obtained for all combinations (Fig. 34 insets). The predicted LLNA EC3 (%) and human 
NOEL (mg/cm2) values for the tested chemicals were then calculated based on the arithmetic 
means of in vitro EC50 or IL-18 SI2 values obtained in two independent experiments. Despite 
different dose response profiles obtained for same chemicals in IL- 18 release, comparing the 
in vitro predicted values with in vivo available data reported in Table 9, with the exception of 
chloramine T for which the LLNA EC3 was underestimated (and no human data is available), 
an excellent correspondence was observed. The predicted LLNA EC3 values were very close 
to the actual values, and each compound remained within the same LLNA class. The predicted 
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human data are more difficult to interpret because of the limited human NOEL data available 
for the tested compounds (de facto available only for imidazolidinyl urea and limonene). For 
the latter two compounds, however, the values were comparable, suggesting that the 
proposed approach can be indeed a valid strategy to estimate the in vivo LLNA EC3 and human 
NOEL starting from in vitro data.  
 
 
Fig. 34 Linear regression curves of RhE assay with LLNA EC3 and human NOEL [30]. (A, B) Regression analysis 
of RhE-EC50 data with LLNA EC3 (A) and human NOEL (B). (B, D) Regression analysis of RhE-IL-18 SI2 data with 
LLNA EC3 (C) and human NOEL (D). Curves were created using data reported in Table 8. R2, p values, relative 
equations and slope errors are reported in each panel, and were calculated using GraphPad Prism (GraphPad 
Software, San Diego, CA, USA).  
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DISCUSSION of “Development of an in vitro method to estimate the sensitization induction 
level of contact allergens”.  
 
While incredible progress has been made in the development of alternative in vitro tests to 
assess contact hypersensitivity, currently it is not possible to estimate sensitizing potency, 
necessary for quantitative risk assessment and full replacement of animals. The third 
objective of my thesis was to provide a simple, mechanistic based in vitro method to classify 
chemicals according to their sensitization potential and to estimate their induction 
sensitization level. Results obtained support the possibility of using the RhE IL-18 assay for 
the identification and potency estimation of contact sensitizers.  
The use of reconstituted epidermis overcomes the limitation of chemical solubility and 
stability in water solution, which are the major limitations of many in vitro methods based on 
the used of submerged cultures. Topical application in relevant vehicles is only possible in RhE 
models, which mimic in vivo chemical bio-availability more closely, and therefore may lead to 
improved assessment of sensitizer potency (Van der Veen et al., 2014; Corsini et al., 2016). 
The predicted potency values we estimated were very close to the actual values, suggesting 
that the proposed approach can indeed be a valid strategy to estimate the in vivo LLNA EC3 
and human NOEL starting from in vitro data. Overall, the arithmetic means of EC50 and IL-18 
SI-2 values obtained in two independent experiments predicted similar in vivo values. The 
advantage of IL- 18 SI-2 is evident in cases of non-cytotoxic compounds for which it is not 
possible to calculate an EC50, e.g. limonene. 
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Table 9. Calculated in vivo LLNA EC3 and human NOEL for the tested chemicals based on in vitro EC50 and IL-
18 SI-2 values [30]. In vivo values were obtained from ICCVAM database (NIH Publication No. 11-7709), Research 
Institute for Fragrance Materials (RIFM) database, Basketter et al. (1996), Griem et al. (2003), Api et al. (2008), 
Natsch et al. (2013), Basketter et al. (2014), Urbisch et al. (2015). In vitro EC50 and IL-18 SI2 were calculated by 
interpolation from linear regression analysis of data reported in Figures 31-33 from RhE exposed to the selected 
compounds as described in the Materials and Methods section. mg/ml values were converted to % and mg/cm2 
for an easier comparison with in vivo data. In vitro values are the mean of two independent experiments. –, 
value not estimated.  
 
Generally, a good relationship between LLNA EC3 values and human repeated insult patch 
test (HRIPT) thresholds was historically shown (Griem et al., 2003; Schneider and Akkan, 2004; 
Basketter et al., 2005) but it is important to mention the limitations associated with the 
human data: a lot of data comes from older studies; human maximization test (HMT) and 
HRIPT have differences in sensitivity; there is not a well standardized protocol; the intrinsic 
potency of chemical skin sensitizers in humans requires experimental studies of dubious 
ethics; and the intraspecies variability of human susceptibility to skin sensitization may 
confound the results (Gerberick et al., 2001; Griem et al., 2003; Schneider and Akkan, 2004; 
Basketter et al., 2005; ICCVAM, 2011). More potent contact allergens are expected to evoke 
at lower concentrations a stronger innate inflammatory reaction than less potent allergens, 
which will in turn influence the migration of skin dendritic cells, their degree of activation and, 
therefore, the quality of immune responses elicited (Kimber et al., 2012). Results obtained 
confirmed the previous ones (Gibbs et al., 2013; Teunis et al., 2014) that showed how there 
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is a general trend for IL-18 induction/cytotoxicity at lower concentrations for extreme/strong 
sensitizers, whereas higher concentrations are required in the case of weak sensitizers. 
The only compound apparently underestimated was chloramine T: an LLNA EC3 value of 
27.14% based on EC50 or of 8.70% based on IL-18 SI-2 were predicted versus a value of 0.14% 
in the animal studies. It is important to mention that in the LLNA positive responses are 
obtained by both contact and respiratory sensitizers, while the RhE IL-18 assay identify only 
contact allergens. It is thus possible that chloramine T would be mainly a type I sensitizer, and 
a weak contact sensitizer. This is likely to be the case in humans, where IgE-mediated allergic 
asthma caused by chloramine T is well known (Wass et al.,1989; Kramps et al.,1981), while 
skin symptoms, mainly allergic contact urticaria, have only seldom been reported (Dooms-
Goossens et al., 1983; Lombardi et al., 1989; Kanerva et al., 1997), perfectly fitting our 
findings.  
Regarding the yes/no classification, based on animal data benzyl salicylate and benzyl 
cinnamate were incorrectly classified as not sensitizers, and 2 non-sensitizers (benzyl alcohol, 
dimethyl isophthalate) were incorrectly classified as sensitizers. However, based on human 
data all chemicals, except dimethyl isophthalate, were correctly classified by the RhE IL-18 
assay. Benzyl salicylate and benzyl cinnamate are fragrance ingredient compounds that can 
be found in cosmetics, shampoos, and toilets soaps as in household cleaners and detergents. 
It has emerged that both compounds, that share a similar chemical structure, are classified 
as not relevant human allergens (Lapczynski et al., 2007; Schnuch et al., 2007; Bhatia et al., 
2007; Ohkawara et al., 2010). Benzyl alcohol is a fragrance used like benzyl salicylate and 
benzyl cinnamate with a different chemical structure. Due to the presence of electronegative 
substituent and a side chain on the aromatic ring able to generate H bonds, benzyl alcohol 
acts as a sensitizer in human (Api et al., 2007; Belsito et al., 2012; Scognamiglio et al., 2012).  
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Dimethyl isophthalate, considered as a not sensitizer in the LLNA, was classified as positive in 
the RhE IL-18 assay, inducing a dose-related release of IL-18. Only few cases of contact allergy 
to dimethyl phthalate has been reported (Capon et al., 1996), which may support our findings 
of dimethyl phthalate being a weak sensitizer.  
A comment should be made regarding 2,4-dichloronitrobenzene, mostly present in 
agrochemical products, which is often used as non-sensitizer structural analog to DNCB in 
animal studies. Even if the weak sensitizing potential of DNCB (LLNA EC3 of 20%) has been 
demonstrated in the LLNA by Basketter et al. (1996), there are evidences in literature that 
this compound is a human contact sensitizer, supporting our results (Basketter et al.,1996; 
Aleksic et al., 2007; Cruz et al., 2007; Roberts and Aptula, 2014).  
To achieve a complete replacement of animals in skin sensitization assessment, dose-
response information and evaluation of relative skin sensitizing potency to support effective 
risk assessment is necessary. Here, a very simple and straightforward approach to estimate 
the LLNA EC3 or human NOEL of a chemical sensitizer has been described. In all biological 
responses, there are of course unavoidable variabilities, which also apply to in vitro and in 
vivo values used in this study. However, when it comes to risk assessment we still tend to use 
one value and apply a safety factor to take care of variability. This is also the case of 
quantitative risk assessment for skin sensitization where to calculate the acceptable exposure 
level, the NESIL is divided by a Sensitization Assessment Factor, which takes care of inter-
individual variability, vehicle and matrix effects, and use considerations (Api et al., 2008).  
In conclusion, even if further compounds must be tested to better define the applicability and 
limitation of the RhE IL-18 potency test, using reference contact allergens, standard curves 
can be created to estimate in vivo sensitization induction level, which can be useful in risk 
assessment. A consortium of academic and industrial partners has now established a generic 
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SOP for the method applicable to several RhE models, and the validation of RhE IL-18 potency 
test is ongoing, results are expected in 2018.  
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                                                                  CHAPTER SEVEN 
                                                                   FUTURE PERSPECTIVES 
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As future perspectives the following experiments can be foreseen: 
 
- To better understanding of the molecular mechanisms of allergen-induced IL-18 
production, the use of antioxidants could be a choice to better explain the role contact 
allegen-induced oxidative stress NLRP12 and Blimp-1 modulation.  
 
- To further study the signal transduction pathways involved in allergen-induced IL-18 
production, the role played by other proteins, should be investigated and may offer 
the possibility to discriminate between weak, strong, extreme sensitizers. 
 
- Finally, a better understanding of the molecular mechanisms underlying potency using 
dendritic cells as experimental model is mandatory to achieve a full replacement of 
animal’s models in contact hypersensitivity.  
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                                                                  ANNEX 
                                                                                Equivalent Epidermis 
                                                                                    VUmc, Amsterdam 
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During my PhD, the Derma Lab of VUmc (Amsterdam) hosted me for three months to learn 
how to make RhE. This experience was done to reproduce RhE at Toxicology Lab (Milan), to 
perform new experiments and to compare the new results with the results previously 
obtained with the NCTC 2544 cell line. 
Below the protocol adopted (all pictures were taken by me). 
For the preparation of an equivalent epidermis of the skin on a dermal matrix or a filter 
matrix, the epidermis can be recreated without the use of fibroblasts. This model gives to 
researcher the opportunity to investigate the role of the keratinocytes by itself in the skin. 
Skin can be stored in 1X Hanks media with 1% pen/strep, at 4°C for maximum 72 h (Fig. 35). 
 
 
 
 
 
Fig. 35 
 
DAY 1 - SKIN PREPARATION (to make foreskin) 
 
Skin from donors (in my case, the Islamic people’s foreskin) was placed in PBS 1X to be washed 
(Fig. 36 left side) and subsequently to be cut (Fig. 36 right side). 
 
 
 
 
Fig. 36 
 
It was necessary to remove the fat part of the skin. In new small Petri’s dish, 4 ml of Dispase 
II (Roche, 295825) were added and the gauze was cut (Fig. 37). The enzyme Dispase II was 
able to promote the epidermal detachment from the dermis. 
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After that, small pieces of skin were cut and put on gauze, with epidermal side up and dermal 
side on the gauze, as shown in Fig. 37: 
 
 
 
 
 
 
Fig. 37 
 
The small Petri’s dish was closed with cap and inserted in a special Petri’s dish (150 mm of 
diameter) to prevent contaminations (Fig. 37 right side) at 4°C, overnight (o.v.). 
 
The day after, the cells were isolated and counted, and a new Petri’s dishes was coated with 
the collagen-IV (Fig. 38). Type IV collagen is a constituent of basement membrane and is 
located especially in the lamina densa. 
 
 
 
 
 
 
 
Fig. 38 
 
By scraper or by swap, collagen-IV solution was spread. Petri’s dishes were incubated at 37°C, 
5% CO2 o.n. The described step could be made also the day after, but in this case it’s necessary 
to wait at least 2 hours (in my case, 4 h). 
 
DAY 2 - KERATINOCYTES ISOLATION 
 
If the Petri’s dishes were coated with collagen VI, it’s possible to start directly. 
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Transfer the special huge Petri’s dish from fridge to incubator for 10-15 min. KC1 media and 
 
0,05% of trypsin solution were used to count the cells: 
 
• KC1 media: 375 mL of DMEM Dulbecco’s modification of Eagle’s Media (Lonza 
company) 
 
125 mL of F-12 NutMix (Ham) (Gibco company, 21765-029) 
5 mL of penicillin/streptomicyn (Gibco, 15070-063) 
 
2 mL of hydrocortisone (Sigma, H-0888) 
 
500 μL of isoproterenol (Sigma, I-6504) 
 
50 μL of Insulin (Sigma, I-5500) 
 
5 mL of UltroserG (GibcoBRL, 091-2950H) 
 
 
• 0,05% of trypsin solution: 20 mL of GNK buffer pH 7.3 
 
500 μL of 1% of EDTA 
 
500 μl of 2.5% Trypsin (GibcoBRL, 25090-028) 
 
It was necessary to detach the epidermis from dermis, a crucial step to prevent epidermis 
contaminations (Fig. 39). 
 
 
 
 
 
Fig. 39 
 
The epidermis was washed 4 times in steril PBS (Fig. 40). 
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Fig. 40 
 
The epidermis was placed in the tube with 5 ml of 0.05% trypsin and was incubated at 37°C 
in the water-bath for 15 min. During this time, a rack with two tubes per donor was prepared. 
On top of the tube 100 μM and 40 μM cell strainer were placed (Fig. 41). 
 
 
 
 
 
 
Fig. 41 
 
The tube with epidermis and trypsin was shacked and 7 ml of media KC1 were added. The 
substance was poured out of the tube on the tube with 100 μM cell strainer. 5 ml of KC1 were 
pipetted on top of the cell strainer to wash it. The 100 μM filter was taken off and was 
discarded it and the cellular solution was poured on to the 40 μM filter tube. Again, 5 ml of 
KC1 were pipetted on top of the cell strainer to wash it. 300-500 μL in a new eppendorf tube 
were kept to count the cells. The filter was discarded, and the tube was centrifuged for 5 min 
at 300 rpm. At the end, the cells are counted by a Burker-turk chamber (Fig. 42): 
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Fig. 42 
 
The cells are counted in 25 squares on the left and 25 on the right, it’s possible to take the 
average. Cells between the double lines were not considered. 
 
Example: on the left I count 35 cells and on the right 29 cells. Then the average is 32 cells 
32 cells X 104 X 20 mL (the volume in the tube) 
6,40 cells X 106 cells 
 
the cells were diluited with medium 1 to 4 X105 cells/ml and 10 ml of cellular suspension were 
put in pre-coated Petri’s dish. 
 
DAY 3 - REFRESH MEDIUM 
 
The media was aspirated carefully and 10 ml + KGF 1 ng/ml were added slowly (for each Petri’s 
dish). If the foreskin was refreshed the day before with KGF, it’s possible to take a look on 
cells and to leave them in the incubator. 
 
DAY 4 - REFRESH MEDIUM 
 
The media was aspirated carefully and 10 ml + KGF 1 ng/ml were added slowly (for each Petri’s 
dish). 
DAY 5 - REFRESH MEDIUM 
 
If the media was not refreshed on day 4, do it on day 5. 
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IMPORTANT: in the Fig. 43 Fibroblasts and KCs morphology is shown on left. When the 
foreskin has a lot of fibroblasts are around the clones of KCs (Fig. 43, on right), they have to 
be removed, as following: the media is removed and is washed twice with 10 ml of steril PBS. 
2 ml of trypsin solution are added. After 1 minute to promote the detach of fibloblasts, the 
solution is removed with vacuum, the cells are washed again with 10 ml of steril PBS slowly 
(to remove trypsin solution) and 10 ml of KC1 and KGF 1 ng/ml are added for each petri’s dish. 
The cells are incubated at 37°C, 1.5% CO2 and 50% humidity. 
 
Fig. 43 Fibroblasts and KCs morfology on left [31]; Fibroblasts around KCs clone on right[  32] 
 
DAY 8 - PUT KERATINOCYTES ON FILTER 
 
From the incubator, KCs were checked under microscope. When confluent, they were 
counted. If the clones of KCs are surrounded of fibroblasts, it is necessary to remove them, as 
described. 
 
KCs were placed on transwell filters a 12 wells filter plate (Fig. 44): 
 
 
 
 
 
Fig. 44 
 
3 ml of KC1 were added outside the traswell; 1 ml of 0,25 X106 cells was added inside. 
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DAY 10 - REFRESH MEDIUM 
 
6-8 mL of KC1 + KGF 1ng/mL in each transwell (in and out) were used to refresh cells. 
 
DAY 14 (Monday) - AIR EXPOSURE 
 
From incubator, the transwell was taken and the media was removed. A special huge Petri’s 
dish (corning, 430597) and a round stainless steel ring with 18 holes was used, 80 mL of KC2+1 
ng/ml of KGF were filled in. Each transwell was checked, and taking care, inserted in each ring 
(Fig. 45, left side). Remind to leave just one hole empty if you have a full Petri’s dish to allow 
the gas exchange (Fig. 45, right side). Take care of air bubbles. 
 
 
 
 
 
 
 
 
Fig. 45 
The equivalent epidermis was incubated. 
 
DAY 17. 
 
80 ml of KC2 + KGF 1ng/ml were used to refresh the equivalent epidermis (EE). EE was 
incubated. 
DAY 21. 
 
80 ml of KC2 + KGF 1ng/ml were used to refresh the EE. EE was incubated. 
 
DAY 24. 
 
80 ml of KC2 + KGF 1ng/ml were used to refresh the EE. EE was incubated. 
 
DAY 27 - CHEMICAL COMPOUND EXPOSURE. 
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PUBLICATIONS: 
 
Papale A, Viscardi V, Lossani C, Galbiati V, Corsini E.  NLRP12 protein and the inflammasome 
complex in the induction of IL-18 in human keratinocytes: further developments 
(manuscript in preparation)  
 
Galbiati V, Papale A, Marinovich M, Gibbs S, Roggen E, Corsini E. Development of an in vitro 
method to estimate the sensitization induction level of contact allergens. Toxicol Lett. 271:1-
11. 2017. 
 
Papale A, Kummer E, Galbiati V, Marinovich M, Galli CL, Corsini E. Understanding chemical 
allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-18 in human 
keratinocytes. Arch Toxicol. 91(4):1783-1794. 2017. 
 
Buoso E, Galasso M, Ronfani M, Papale A, Galbiati V, Eberini I, Marinovich M, Racchi M, 
Corsini E. The scaffold protein RACK1 is a target of endocrine disrupting chemicals (EDCs) with 
important implication in immunity. Toxicol Appl Pharmacol. 325:37-47. 2017. 
 
Corsini E, Vecchi R, Marabini L, Fermo P, Becagli S, Bernardoni V, Caruso D, Corbella L, 
Dell'Acqua M, Galli CL, Lonati G, Ozgen S, Papale A, Signorini S, Tardivo R, Valli G, Marinovich 
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V, Dell'Acqua M, Becagli S, Caruso D, Vecchi R, Galli CL, Marinovich M. Insights on wood 
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Hyaluronan regulates chemical allergen-induced IL-18 production in human keratinocytes. 
Toxicol Lett. 232(1):89-97. 2015. 
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dibutyl phthalate (DBP) potentiates chemical allergen-induced THP-1 activation. Toxicol In 
Vitro 29(8):2001-8. 2015. 
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ACTIVITIES: 
Internship abroad:  
November 2016-february 2017. VU Medical Centre, Dermatology Laboratory, directed by 
Prof. Sue Gibbs, Amsterdam, The Netherlands. 
 
Oral communications: 
- “Role of inflammasome proteins in the induction of IL-18 in the human keratinocytes 
cell line NCTC 2544”, ERGECD 2017, Zurig, Swizzerland. 
- “Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in 
Keratinocytes”, ERGECD 2015, Milan, Italy. 
- “Sviluppo di un metodo in vitro per stimare il livello di induzione della 
sensibilizzazione da parte di allergeni da contatto a basso peso molecolare”, SITOX 
2015, Milan, Italy. 
 
Poster presentations: 
- “NLRP12 protein and the inflammasome complex in the induction of IL-18 in the 
human keratynocites: further developments”, EUROTOX 2017, Bratislava, Slovak. 
- “Molecular mechanisms involved in allergen-induced IL-18 production in the human 
keratinocytes cell line”, ESTIV 2015, Egmond Aan Zee, The Netherlands. 
 
Correlator of experimental thesis: 
- “Ruolo delle proteine dell’inflammasoma NLRP3 nell’induzione di IL-18 nella linea di 
cheratinociti umani NCTC 2544”. Student: Veronica Viscardi. Anno accademco 
2016/2017. 
- “Espressione delle proteine dell’inflammasoma NLRP3 e link con la proteina NLRP12 
nell’induzione di IL-18 nella linea di cheratinociti umani NCTC 2544”. Student: Chiara 
Lossani. Anno accademico 2017/2018. 
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